Pt	Center	Center_Code	Cohort_Global	Cohort_Treatment	Cohort_Cazavi	Cohort_BAT	Cohort_Combi	Cazavi_avaibility	Clinical_success_14d	Clinical_success_30d	Time2death_31d	Mortality_31d	Bloodculture	Antibiogram	Targeted_defAJT	Time2activetreatment	Carbapenemase	Guidelines	ATB1	ATB1_MIC	ATB1_SIR	ATB1_DOSE	ATB1_start	ATB1_end	ATB1_reason2stop	ATB2	ATB2_MIC	ATB2_SIR	ATB2_DOSE	ATB2_start	ATB2_end	ATB2_reason2stop	ATB3	ATB3_MIC	ATB3_SIR	ATB3_DOSE	ATB3_start	ATB3_end	ATB3_reason3stop	ATB4	ATB4_MIC	ATB4_SIR	ATB4_DOSE	ATB4_start	ATB4_end	ATB4_reason4stop	ATB5	ATB5_MIC	ATB5_SIR	ATB5_DOSE	ATB5_start	ATB5_end	ATB5_reason5stop	ATB6	ATB6_MIC	ATB6_SIR	ATB6_DOSE	ATB6_start	ATB6_end	ATB6_reason2stop	ATB7	ATB7_MIC	ATB7_SIR	ATB7_DOSE	ATB7_start	ATB7_end	ATB7_reason2stop	ATB8	ATB8_MIC	ATB8_SIR	ATB8_DOSE	ATB8_start	ATB8_end	ATB8_reason2stop	ATB9	ATB9_MIC	ATB9_SIR	ATB9_DOSE	ATB9_start	ATB9_end	ATB9_reason2stop	ATB10	ATB10_MIC	ATB10_SIR	ATB10_DOSE	ATB10_start	ATB10_end	ATB10_reason2stop	ATB11	ATB11_MIC	ATB11_SIR	ATB11_DOSE	ATB11_start	ATB11_end	ATB11_reason2stop	ATB12	ATB12_MIC	ATB12_SIR	ATB12_DOSE	ATB12_start	ATB12_end	ATB12_reason2stop	ATB13	ATB13_MIC	ATB13_SIR	ATB13_DOSE	ATB13_start	ATB13_end	ATB13_reason2stop
1	FMUSP	Brasil_2	yes	yes	no	yes	no	neutral	yes	yes	31	no	02/08/17	02/12/17	TGC	4	KPC	CLSI	Meropenem	>16	R	1g/8h	2017-02-08	2017-02-28	Improvement	Colistin	>16	R	150mg/12h	2017-02-08	2017-02-12	Microbiologival report	Amikacin	<2	S	750mg/24h	2017-02-08	2017-02-08	Improvement	Tigecycline	2	S	50mg/12	2017-02-12	2017-02-28	Improvement																																																															
2	FMUSP	Brasil_2	yes	no	no	no		neutral	no	no	29	yes	05/03/17	05/07/17	COL+TGC	-21	KPC	CLSI	Meropenem	>16	R	1g/8h	2017-04-12	2017-05-25	Defined palliative care	Colistin	<0,5	S	50mg/24h	2017-04-12	2017-05-25	Defined palliative care	Tigecycline	4	I	100mg/12	2017-05-03	2017-05-25	Defined palliative care	Ertapenem	>8	R	500mg/8h	2017-05-07	2017-05-25	Defined palliative care																																																															
3	FMUSP	Brasil_2	yes	yes	no	yes	no	neutral	yes	yes	31	no	08/22/17	08/25/17	COL	0	KPC	CLSI	Amikacin	4	S	500mg/48	2017-08-22	2017-09-01	Intolerance	Colistin	<0,5	S	50mg/12h	2017-08-22	2017-09-17	Improvement	Meropenem	>16	R	500mg/12h	2017-08-24	2017-09-17	Improvement	Tigecycline	>8	R	50mg/12	2017-09-10	2017-09-17	Improvement																																																															
4	FMUSP	Brasil_2	yes	no	no	no		neutral	no	no	8	yes	10/02/18	10/08/18	COL+TGC	6	KPC	CLSI	Meropenem	>16	R	1g/12h	2021-09-28	2021-10-04	Unnecesary	Meropenem	>16	R	1g/8h	2021-10-08	2021-10-10	Death	Colistin	<0.5	S	150mg/12h	2021-10-08	2021-10-10	Death	Tigecycline	2	S	50mg/12h	2021-10-08	2021-10-10	Death																																																															
5	FMUSP	Brasil_2	yes	no	no	no		neutral	no	no	17	yes	02/13/19	02/20/19	TGC	-9	KPC	CLSI	Ciprofloxacin	>4	R	400mg/12h	2021-01-24	2021-01-29	More convenient alternative	Ceftriaxone	>64	R	1g/12h	2021-01-29	2021-02-04	Microbiologival report	Meropenem	>16	R	2g/8h	2021-02-04	2021-03-02	Death	Amikacin	16	S	1g/24h	2021-02-04	2021-03-02	Death	Colistin	>16	R	150mg/12h	2021-02-04	2021-02-20	Microbiologival report	Ertapenem	>8	R	1g/24h	2021-02-20	03/02/21	Death	Tigecycline	4	S	100mg/12h	2021-02-20	2021-03-02	Death																																										
6	FMUSP	Brasil_2	yes	yes	no	yes	no	neutral	yes	yes	31	no	02/13/19	02/16/19	COL	0	KPC	CLSI	Amikacin	<2	S	500mg/24h	2019-02-13	2019-02-21	Improvement	Colistin	<0.5	S	50mg/12h	2019-02-13	2019-02-21	Improvment	Meropenem	>16	R	500mg/12h	2019-02-16	2019-02-21	Improvment																																																																						
7	FMUSP	Brasil_2	yes	yes	no	yes	no	neutral	no	no	11	yes	04/26/19	04/30/19	COL	2	KPC	CLSI	Meropenem	>16	R	1g/8h	2019-04-26	2019-04-29	Microbiological report	Colistin	<0.5	S	100mg/12h	2019-04-28	2019-05-07	Death	Tigecycline	<0.5	S	100mg/12h	2019-04-28	2019-05-07	Death																																																																						
8	FMUSP	Brasil_2	yes	yes	no	yes	no	neutral	yes	yes	31	no	07/02/19	07/07/19	TGC	3	KPC	CLSI	Polymyxin	>16	R	500.000 UI/12h	2019-06-22	2019-07-07	More convenient alternative	Meropenem	>16	R	2g/8h	2019-06-22	2019-07-20	Improvement	Ampicillin	>32	R	2g/6h	2019-06-29	2019-07-05	More convenient alternative	Tigecycline	2	S	100mg/12h	2019-07-05	2019-07-20	Improvement	Ertapenem	>8	R	1g/24h	2019-07-07	2019-07-20	Improvement																																																								
9	FMUSP	Brasil_2	yes	yes	no	yes	yes	neutral	no	no	10	yes	07/06/19	07/12/19	COL+TGC	2	KPC	CLSI	Meropenem	>16	R	2G/8h	2019-06-26	2019-07-10	Not improvement	Colistin	<0.5	S	150MG/12h	2019-07-08	2019-07-16	Death	Tigecycline	2	S	50mg/12h	2019-07-08	2019-07-16	Death																																																																						
10	FMUSP	Brasil_2	yes	yes	no	yes	no	neutral	no	no	18	yes	02/18/20	02/25/20	TGC	2	KPC	CLSI	Meropenem	>16	R	1g/8h	2020-02-20	2020-03-07	Death	Ertapenem	>8	R	1g/24h	2020-02-20	2020-03-07	Death	Tigecycline	4	I	50mg/12h	2020-02-20	2020-03-07	Death																																																																						
11	FMUSP	Brasil_2	yes	no	no	no		neutral	yes	yes	31	no	04/27/20	05/06/20	COL	8	KPC	CLSI	Meropenem	>16	R	2G/8h	2020-04-25	2020-06-02	Improvement	Colistin	<0.5	S	150mg/12h	2020-05-06	2020-06-02	Improvement	Amikacin	<2	S	800mg/24h	2020-05-06	2020-06-02	Improvement																																																																						
12	FMUSP	Brasil_2	yes	no	no	no		neutral	no	no	5	yes	08/03/20	08/05/20	COL	-6	KPC	CLSI	Meropenem	>16	R	500mg/12h	2020-07-19	2020-08-05	Microbiological report	Polymyxin	<0.5	S	750,000 UI/12h	2020-07-28	2020-08-08	Death	Amikacin	<2	S	500mg/24h	2020-08-05	2020-08-08	Death																																																																						
13	FMUSP	Brasil_2	yes	yes	yes	no	no	neutral	no	no	5	yes	05/25/21	05/30/21	CAZAVI	-1	KPC	CLSI	Ceftriaxone	>64	R	1g/12h	2021-05-15	2021-05-24	Not improvement	Amikacin	>64	R	1g/8h	2021-05-19	2021-05-30	Death	CAZ-AVI		S	1,250mg/8h	2021-05-24	2021-05-30	Death																																																																						
14	FMUSP	Brasil_2	yes	no	no	no		neutral	no	no	4	yes	07/17/21	07/22/21	No_active_therapy		KPC	CLSI	Ceftriaxone	>64	R	1g/12h	2021-07-10	2021-07-19	Not improvment																																																																																				
15	Gemelli	Italy_4	yes	yes	no	yes	no	high	yes	yes	31	no	08/10/16	08/14/16	COL	1	KPC	EUCAST	Meropenem	>16	R	1/12H	2016-08-11	2016-08-23	end therapy	Colistin	<0,5	S	3MU/12h	2016-08-11	2016-08-23	end therapy																																																																													
16	Gemelli	Italy_4	yes	yes	no	yes	no	high	no	no	16	yes	05/08/16	05/09/16	COL	0	KPC	EUCAST	Colistin	<0,5	S	2MU/12h	2016-05-08	2016-05-24	death	Meropenem	>16	R	1G/8H	2016-05-10	2016-05-24	death	Tigecycline		NR	100MG/12H	2016-05-18	2016-05-24	death																																																																						
17	Gemelli	Italy_4	yes	yes	no	yes	no	high	yes	yes	31	no	09/02/16	09/03/16	COL	-1	KPC	EUCAST	Meropenem	16	R	2/12H	2016-09-01	2016-09-14	end therapy	Tigecycline	2	I	50/12h	2016-09-01	2016-09-14	end therapy	Colistin	<1	S	2MU/12h	2016-09-01	2016-09-14	end therapy																																																																						
18	Gemelli	Italy_4	yes	yes	no	yes	no	high	yes	yes	31	no	04/07/16	04/08/16	COL	3	KPC	EUCAST	Meropenem	>16	R	1/8H	2016-04-07	2016-04-09	end therapy	Colistin	<0,5	S	3MU/12h	2016-04-10	2016-04-16	end therapy																																																																													
19	Gemelli	Italy_4	no	no	no	no		high	no	no	2	yes	03/20/16	03/21/16	No_active_therapy		KPC	EUCAST	Meropenem	>16	R		2016-03-20	2016-03-22	death	Colistin	>16	R		2016-03-21	2016-03-22	death																																																																													
20	Gemelli	Italy_4	yes	yes	yes	no	yes	high	yes	yes	31	no	08/08/18	08/09/18	CAZAVI+TGC	-2	KPC	EUCAST	CAZ-AVI	2	s	1,25/8h	2018-08-08	2018-09-27	end therapy	Tigecycline	1.5	I		2018-08-05	2018-09-14	end therapy	Meropenem	>16	R		2018-08-01	2018-08-09	microbiological report	TMP/SMX	>320	R		2018-08-05	2018-08-09	microbiological report																																																															
21	Gemelli	Italy_4	yes	yes	yes	no	no	high	no	no	5	yes	11/22/18	11/23/18	CAZAVI	1	KPC	EUCAST	Meropenem	>64	R		2018-11-22	2018-11-23	micro report	CAZ-AVI	<1	S	1G/12	2018-11-23	2018-11-27	death	Gentamicin	0.5	S		2018-11-23	2018-11-27	end therapy																																																																						
22	Gemelli	Italy_4	yes	yes	yes	no	no	high	yes	yes	31	no	06/01/18	06/02/18	CAZAVI	0	KPC	EUCAST	CAZ-AVI	2	S	0,94/48h	2018-06-01	2018-06-10	end therapy																																																																																				
23	Gemelli	Italy_4	yes	yes	yes	no	no	high	yes	yes	31	no	11/20/18	11/21/18	CAZAVI	1	KPC	EUCAST	Piperacilin-Tazobactam	>16	R	4,5g/8h	2018-11-20	2018-11-21	micro report	CAZ-AVI	2	S	1,25/8h	2018-11-21	2018-12-14	end therapy																																																																													
24	Gemelli	Italy_4	yes	yes	yes	no	yes	high	yes	yes	31	no	10/01/18	10/03/18	CAZAVI+TGC	-2	KPC	EUCAST	Meropenem	>32	R		2018-09-29	2018-10-24	end therapy	Tigecycline	2	I		2018-09-29	2018-10-24	end therapy	CAZ-AVI	4	S	1g/12h	2018-10-06	2018-10-24	end therapy																																																																						
25	Gemelli	Italy_4	yes	yes	yes	no	no	high	no	no	25	yes	11/08/18	11/09/18	CAZAVI	1	KPC	EUCAST	CAZ-AVI	<1	s	1,25/8h	2018-11-09	2018-12-03	death	Meropenem	16	R		2018-11-10	2018-12-03	death	Tigecycline		NR		2018-11-30	2018-12-03	death																																																																						
26	Gemelli	Italy_4	yes	yes	yes	no	no	high	yes	yes	31	no	05/15/19	05/17/19	CAZAVI	1	KPC	EUCAST	Meropenem	>64	R		2019-05-10	2019-02-24	unnecessary	Colistin	<1	S		2019-05-16	2019-05-17	more convenient alternative	CAZ-AVI	2	S	1g/12h	2019-05-17	2019-05-26	end therapy																																																																						
27	Gemelli	Italy_4	yes	yes	yes	no	yes	high	yes	yes	31	no	07/19/19	07/20/19	CAZAVI+FMN	1	KPC	EUCAST	Meropenem	>16	R		2019-07-19	2019-07-20	micro report	CAZ-AVI	2	S	0.94	2019-07-20	2019-08-10	end therapy	Gentamicin	2	S		2019-07-20	2019-07-21	more convenient alternative	Fosfomycin		NR		2019-07-24	2019-08-10	end therapy	Tigecycline	1	S		2019-07-24	2019-08-09	end therapy																																																								
28	Gemelli	Italy_4	yes	yes	yes	no	no	high	yes	yes	31	no	01/17/19	01/19/19	CAZAVI	0	KPC	EUCAST	Meropenem	>16	R		2019-01-17	2019-01-19	micro report	CAZ-AVI	4	S	1,25/8H	2019-01-17	2019-01-28	end therapy																																																																													
29	Gemelli	Italy_4	yes	yes	yes	no	no	high	yes	yes	31	no	03/03/19	03/06/19	CAZAVI	1	KPC	EUCAST	Ceftriaxone			2/24h	2019-03-03	2019-03-04	micro report	CAZ-AVI	<1	S	2,5/8h	2019-03-04	2019-03-14	end therapy																																																																													
30	Gemelli	Italy_4	yes	no	no	no		high	yes	yes	31	no	12/28/20	12/30/20	TGC	1	KPC	EUCAST	Tigecycline	0.5	S		2020-12-29	2021-01-30	end therapy	Meropenem	8	R		2020-12-29	2021-01-05	microbiological report	CAZ-AVI	<1	S	1.23/8h	2021-01-05	2021-01-30	end therapy																																																																						
31	Gemelli	Italy_4	yes	yes	yes	no	yes	high	yes	yes	31	no	01/09/20	01/11/20	CAZAVI+TGC	0	KPC	EUCAST	Meropenem	>32	R		2020-01-09	2020-01-11	micro report	Tigecycline	2	I		2020-01-09	2020-01-29	end therapy	CAZ-AVI	4	S	2.5/8H	2020-01-11	2020-02-01	end therapy																																																																						
32	Gemelli	Italy_4	yes	yes	yes	no	yes	high	yes	yes	31	no	07/27/20	07/29/20	CAZAVI+COL	5	KPC	EUCAST	CAZ-AVI	2	S	2.3/8H	2020-08-01	2020-08-14	end therapy	Meropenem	>32	R		2020-08-01	2020-08-14	end therapy	Colistin	125	S	0	2020-08-01	2020-08-14	end therapy																																																																						
33	Gemelli	Italy_4	yes	yes	yes	no	no	high	yes	yes	31	no	01/31/21	02/02/21	CAZAVI	3	KPC	EUCAST	Meropenem	16	R		2021-01-30	2021-02-02	micro report	CAZ-AVI	<1	S	1.25/8H	2021-02-02	2021-03-12	end therapy							0																																																																						
34	Gemelli	Italy_4	yes	yes	yes	no	yes	high	yes	yes	31	no	03/10/21	03/12/21	CAZAVI+COL	2	KPC	EUCAST	CAZ-AVI	2	S	0.94/48h	2021-03-12	2021-04-02	end therapy	Colistin	<1	S		2021-03-13	2021-03-21	unnecesary							0																																																																						
35	Gemelli	Italy_4	yes	yes	yes	no	no	high	yes	yes	31	no	07/13/21	07/14/21	CAZAVI	1	KPC	EUCAST	CAZ-AVI	2	S	2,5/8H	2021-07-14	2021-07-28	end therapy	Meropenem	16	R		2021-07-14	2021-07-28	end therapy							0																																																																						
36	Hospital_Clinic_Barcelona	Spain_5	yes	yes	yes	no	no	high	yes	yes	31	no	01/22/16	01/24/16	CAZAVI	4	OXA-48	EUCAST	CAZ-AVI		S	2gr/8h	2016-01-26	2016-02-09																																																																																					
37	Hospital_Clinic_Barcelona	Spain_5	yes	yes	yes	no	no	high	yes	yes	31	no	06/14/17	06/17/17	CAZAVI	1	OXA-48	EUCAST	CAZ-AVI		S	2gr/8h	2017-06-15	2017-06-30		Ertapenem	>1	R	1gr/24h	2017-06-14	2017-06-15	Microbiological report	Tigecycline	1	S	50mg/12h	2017-06-15	2017-06-30																																																																							
38	Hospital_Clinic_Barcelona	Spain_5	yes	yes	yes	no	no	high	yes	yes	31	no	07/10/17	07/12/17	CAZAVI	2	OXA-48	EUCAST	CAZ-AVI		S	2gr/8h	2017-07-12	2017-07-24																																																																																					
40	Hospital_Clinic_Barcelona	Spain_5	yes	yes	yes	no	no	high	yes	yes	31	no	11/27/20	11/28/20	CAZAVI	2	OXA-48	EUCAST	Meropenem	>8	R	2g/8h	2020-11-27	2020-11-28	Microbiological report	CAZ-AVI	2(4	S	2gr/8h	2020-11-29	2020-12-14	End of treatment																																																																													
41	Hospital_Clinic_Barcelona	Spain_5	yes	yes	yes	no	no	high	yes	yes	31	no	05/14/21	05/15/21	CAZAVI	-1	OXA-48	EUCAST	Meropenem	>8	R	1gr/12h	2021-05-12	2021-05-13	Microbiological report	CAZ-AVI	2(4	S	2gr/8h	2021-05-13	2021-05-28	End of treatment																																																																													
42	Hospital_Clinic_Barcelona	Spain_5	yes	yes	yes	no	no	high	yes	yes	31	no	11/14/20	11/15/20	CAZAVI	0	OXA-48	EUCAST	CAZ-AVI	2(4	S	2gr/8h	2020-11-14	2020-11-20	Microbiological report	Meropenem		S	2gr/8h	2020-11-20	2020-12-09	End of treatment																																																																													
43	Hospital_Clinic_Barcelona	Spain_5	yes	yes	yes	no	no	high	yes	yes	31	no	01/21/21	01/22/21	CAZAVI	0	OXA-48	EUCAST	CAZ-AVI	1(4	S	2gr/8h	2021-01-21	2021-02-01	end of treatment. Cure																																																																																				
44	Hospital_Clinic_Barcelona	Spain_5	yes	yes	yes	no	no	high	yes	yes	31	no	02/14/21	02/15/21	CAZAVI	0	OXA-48	EUCAST	CAZ-AVI	2(4	S	2gr/8h	2021-02-14	2021-03-15	end of treatment. Cure																																																																																				
45	Hospital_Clinic_Barcelona	Spain_5	yes	yes	yes	no	no	high	yes	yes	31	no	01/17/20	01/18/20	CAZAVI	2	OXA-48	EUCAST	Meropenem	>8	R	2gr/8h	2020-01-17	2020-01-19	Microbiological report	CAZ-AVI		S	2gr/8h	2020-01-19	2020-03-05	End of treatment																																																																													
46	Hospital_Clinic_Barcelona	Spain_5	yes	yes	no	yes	no	high	yes	yes	31	no	11/25/20	04/30/20	MRP	1	OXA-48	EUCAST	Piperacilin-Tazobactam	>64(4	R	4gr/6h	2020-11-25	2020-11-26	Microbiological report	CAZ-AVI	2(4	S	2gr/8h	2020-11-26	2020-11-27	microbiological report	Meropenem	0.25	S	2gr/8h	2020-11-27	2020-12-04	Cure																																																																						
47	Hospital_Clinic_Barcelona	Spain_5	yes	yes	no	yes	no	high	yes	yes	31	no	04/29/20	11/26/20	COL	0	OXA-48	EUCAST	CAZ-AVI	>8/4	R	2gr/8h	2020-04-29	2020-05-14	end of treatment. Cure	Aztreonam	>16	R	1gr/8h	2020-04-29	2020-05-14	End of treatment	Colistin	<=0,5	S	3Mu/8h	2020-04-29	2020-05-14	end of treatment																																																																						
48	Hospital_Clinic_Barcelona	Spain_5	yes	yes	yes	no	no	high	yes	yes	31	no	09/30/19	10/01/19	CAZAVI	1	OXA-48	EUCAST	Meropenem	>8	R	2gr/12h	2019-09-30	2019-10-01	Microbiological report	CAZ-AVI	4	S	2gr/12h	2019-10-01	2019-10-22	End of treatment																																																																													
49	HCKT	Brasil_1	yes	no	no	no		low	yes	yes	31	no	11/19/16	11/22/16	No_active_therapy		KPC	CSLI	Ertapenem	>8	R	1g/24h	2016-11-22	2016-12-04		Meropenem	>16	R	1g 8/8h	2016-11-20	2016-12-04		Fosfomycin		NR	3G/8/8	2016-11-22	2016-12-04		Tigecycline	1	S	100 mg 12/12	2016-11-22	2016-12-04																																																																
50	HCKT	Brasil_1	yes	yes	no	yes	no	low	no	no	30	yes	03/11/16	03/15/16	COL	0	KPC	CLSI	Meropenem	>16	R	500 mg 12/12h	2016-03-11	2016-03-21		Polymyxin	<0.5	S	500000UI 12/12h	2016-03-11	2016-03-24																																																																														
51	HCKT	Brasil_1	yes	no	no	no		low	no	no	25	yes	02/08/16	02/13/16	No_active_therapy		KPC	CLSI	Colistin	>16	R	120mg 12/12h	2016-01-10	2016-01-25	Not improvement	Polymyxin	>16	R	1MUI 12/12H	2016-01-25	2016-02-11	intolerance	Amikacin	>64	R	500mg 48/48h	2016-01-26	2016-02-11		Tigecycline	2	S	50mg 12/12h	2016-02-11	2016-03-04		Meropenem	>16	R	1g 12/12h	2016-02-11	2016-03-04		Colistin	>16	R	120mg 12/12h	2016-02-11	2016-03-04																																																		
52	HCKT	Brasil_1	yes	yes	no	yes	no	low	yes	yes	31	no	01/19/16	01/24/16	COL	0	KPC	CLSI	Amikacin	>64	R	500mg 24/24h	2016-01-13	2016-01-19	Microbiological report	Colistin	<0,5	S	110mg 12/12h	2016-01-19	2016-02-02																																																																														
53	HCKT	Brasil_1	yes	yes	no	yes	no	low	yes	yes	31	no	02/23/16	02/28/16	FMN	0	KPC	CLSI	Meropenem	>16	R	2 g 8/8 h	2016-02-22	2016-03-08		Fosfomycin		NR	3gr 24/24h	2016-02-23	2016-03-08		Tigecycline	2	S	100mg 12/12	2016-02-23	2016-03-08									Ertapenem	>8	R	1g 24/24h	2016-02-26	2016-03-08																																																									
54	HCKT	Brasil_1	yes	no	no	no		low	no	yes	31	no	01/07/16	01/11/16	No_active_therapy	0	KPC	CLSI	Meropenem	>16	R	2 g 8/8 h	2016-01-07	2016-01-28		Tigecycline	2	S	50mg 12/12h	2016-01-07	2016-01-28		Amikacin	>64	R	500mg 24/24h	2016-01-07	2016-01-16	Microbiological report	Fosfomycin		NR	3g 24/24h	2016-01-13	2016-02-05																																																																
55	HCKT	Brasil_1	yes	no	no	no		low	no	no	6	yes	06/10/16	06/14/16	No_active_therapy		KPC	CLSI	Meropenem	>16	R	1 g 8/8 h	2016-06-10	2016-06-16		Amikacin	>64	R	500 mg 48/48h	2016-06-10	2016-06-12	Microbiological report	Colistin	>16	R	120mg 12/12h	2016-06-10	2016-06-16		Ertapenem	>8	R	1 gr 24/24h	2016-06-12	2016-06-16		Tigecycline	2	S	100mg 12/12	2016-06-12	2016-06-16																																																									
56	HCKT	Brasil_1	yes	no	no	no		low	no	yes	31	no	05/30/16	06/03/16	No_active_therapy		KPC	CLSI	Meropenem	>16	R	1g 8/8h	2016-05-30	2016-06-18	More conveniente alternative (vascular access)	Amikacin	8	S	500 mg 24/24h	2016-05-30	2016-06-26		Ertapenem	>8	R	1 gr 24/24h	2016-06-18	2016-06-26																																																																							
57	HCKT	Brasil_1	yes	no	no	no		low	no	no	25	yes	07/31/16	08/04/16	No_active_therapy	12	KPC	CLSI	Meropenem	>16	R	2 g 8/8 h	2016-08-02	2016-08-12	Not improvement	Tigecycline	2	S	100mg 12/12h	2016-08-02	2016-08-25		Polymyxin	>16	R	1M 12/12h	2016-08-02	2016-08-09	Microbiological report	Ertapenem	>8	R	1g 24/24h	2016-08-04	2016-08-12	Not improvement	Fosfomycin		NR	3g 24/24h	2016-08-04	2016-08-12	Not improvement	CAZ-AVI		S	1,250mg 12/12h	2016-08-12	2016-08-25																																																		
58	HCKT	Brasil_1	yes	no	no	no		low	yes	yes	31	no	03/20/16	03/24/16	No_active_therapy		KPC	CLSI	Meropenem	>16	R	1g 8/8h	2016-03-20	2016-04-19		Tigecycline	2	S	100 mg 12/12h	2016-03-20	2016-04-19		Colistin	>16	R	100mg 24/24h	2016-03-20	2016-03-23	Microbiological report	Amikacin	>=64	R	300 mg 48/48h	2016-03-20	2016-04-01	Microbiological report																																																															
59	HCKT	Brasil_1	yes	no	no	no		low	yes	yes	31	no	10/21/16	26/102016	No_active_therapy	0	KPC	CLSI	Meropenem	>16	R	2 g 8/8 h	2016-10-21	2016-11-03		Tigecycline	2	S	100 mg 12/12h	2016-10-21	2016-11-03		Ertapenem	>8	R	500mg 8/8h	2016-10-21	2016-11-03		Fosfomycin		NR	3g 24/24h	2016-10-21	2016-11-03																																																																
60	HCKT	Brasil_1	yes	yes	no	yes	no	low	yes	yes	31	no	10/02/16	10/08/16	COL	1	KPC	CLSI	Colistin	<0,5	S	100 mg 8/8h	2016-10-03	2016-10-17																																																																																					
61	HCKT	Brasil_1	yes	yes	no	yes	no	low	no	no	11	yes	10/24/16	10/29/16	COL	3	KPC	CLSI	Amikacin	4	S	500mg 24/24h	2016-10-24	2016-10-27	intolerance	Colistin	<0.5	S	100 mg 12/12h	2016-10-27	2016-11-01		Tigecycline	2	S	50 mg 12/12h	2016-10-28	2016-11-01																																																																							
62	HCKT	Brasil_1	yes	yes	yes	no	no	low	no	no	18	yes	11/07/16	11/12/16	CAZAVI	0	KPC	CLSI	Ertapenem	>8	R	1g 8/8h	2016-11-07	2016-11-11	Not improvement	Fosfomycin		NR	3gr 24/24h	2016-11-07	2016-11-11	Not improvement	Meropenem	>16	R	1g 8/8h	2016-11-07	2016-11-11	Not improvement	Tigecycline	2	S	100mg 12/12	2016-11-07	2016-11-11	Not improvement	CAZ-AVI		S	1250mg 24/24h	2016-11-11	2016-11-25		Colistin	>16	R	100mg 8/8h	2016-11-24	2016-11-25																																																		
63	HCKT	Brasil_1	yes	no	no	no		low	yes	yes	31	no	02/24/16	02/27/16	No_active_therapy	0	KPC	CLSI	Meropenem	>16	R	1 g 8/8 h	2016-02-24	2016-03-09		Fosfomycin		NR	3gr 24/24h	2016-02-24	2016-03-09		Tigecycline	2	S	100mg 12/12	2016-02-24	2016-03-09																																																																							
65	HCKT	Brasil_1	yes	yes	no	yes	no	low	yes	yes	31	no	06/07/17	06/10/17	AMG	2	KPC	CLSI	Amikacin	4	S	500 mg24/24H	2017-06-09	2017-07-05																																																																																					
66	HCKT	Brasil_1	yes	yes	no	yes	yes	low	yes	yes	31	no	09/06/17	09/09/17	AMG+COL	3	KPC	CLSI	Meropenem	>16	R	1g 12/12h	2017-09-06	2017-09-21		Colistin	<0,5	S	150 mg 12/12h	2017-09-09	2017-09-11	Unnecesary	Amikacin	4	S	500mg 24/24h	2017-09-09	2017-09-22																																																																							
67	HCKT	Brasil_1	yes	yes	no	yes	no	low	yes	yes	31	no	05/19/17	05/23/17	COL	0	KPC	CLSI	Colistin	<0.5	S	150mg/24H	2017-05-19	2017-06-02		Amikacin	16	S	1g 24/24h	2017-05-21	2017-05-25	Intolerance	Amikacin	16	S	1G/24H	2017-05-30	2017-06-14																																																																							
68	HCKT	Brasil_1	yes	no	no	no		low	no	no	4	yes	09/26/17	09/28/17	No_active_therapy		KPC	CLSI	Meropenem		R	2G/ 8/8H	2017-09-28	2017-09-30		Ertapenem		R	1g 24/24h	2017-09-28	2017-09-30		Tigecycline		S	200mg/24H	2017-09-21	2017-09-30		Amikacin		S	500mg/24H	2017-09-21	2017-09-30		Colistin		R	150MG/24H	2017-09-15	2017-09-30																																																									
69	HCKT	Brasil_1	yes	no	no	no		low	no	no	4	yes	08/18/17	08/23/17	No_active_therapy		KPC	CLSI	Meropenem	>16	R	1g 8/8h	2017-08-11	2017-08-21																																																																																					
70	HCKT	Brasil_1	yes	no	no	no		low	no	no	9	yes	09/03/17	09/08/17	COL	-9	KPC	CLSI	Colistin	<0,5	S	150 mg /24h	2017-08-25	2017-09-12	Not improvement	Meropenem	>16	R	1g 8/8h	2017-08-25	2017-09-12	Not improvement	Tigecycline	2	S	100mg/12/12	2017-09-04	2017-09-12	Not improvement																																																																						
71	HCKT	Brasil_1	yes	yes	no	yes	no	low	yes	yes	31	no	05/29/17	06/01/17	COL	4	KPC	CLSI	Meropenem	16	R	2g/ 8/8	2017-06-02	2017-06-21		Colistin	2	S	200 mg/24	2017-06-02	2017-07-21																																																																														
72	HCKT	Brasil_1	yes	yes	no	yes	no	low	no	no	28	yes	11/21/17	11/26/17	COL	5	KPC	CLSI	Meropenem	>16	R	1 gr 12/12	2017-11-20	2017-12-19		Colistin	<0,5	S	150mg 12/12	2017-11-26	2017-12-04	Not improvement																																																																													
73	HCKT	Brasil_1	yes	no	no	no		low	no	no	3	yes	03/13/17	03/16/17	No_active_therapy		KPC	CLSI	Meropenem	>16	R	1 gr 12/12	2017-03-14	2017-03-16		Amikacin	16	S	500 mg 48/48	2017-03-15	2017-03-16		Tigecycline	2	S	100 mg 12/12	2017-03-15	2017-03-16		Ertapenem	>8	R	1 g 24/24h	2017-03-15	2017-03-16																																																																
74	HCKT	Brasil_1	yes	yes	no	yes	no	low	yes	yes	31	no	04/07/17	04/11/17	AMG	3	KPC	CLSI	Amikacin	16	S	1GR 24/24H	2017-04-10	2017-04-20																																																																																					
75	HCKT	Brasil_1	yes	yes	no	yes	no	low	no	no	31	no	03/25/18	03/28/18	COL	1	KPC	CLSI	Meropenem	>16	R	1g 12/12h	2018-03-25	2018-03-30	Microbiological report	Amikacin	4	S	500mg 24/24h	2018-03-29	2018-04-14		Colistin	<0.5	S	150mg/24H	2018-03-26	2018-04-09																																																																							
76	HCKT	Brasil_1	yes	yes	no	yes	no	low	no	no	3	yes	11/26/18	12/04/18	COL	0	KPC	CLSI	Colistin	<0,5	S	150 mg 12/12	2018-11-26	2018-11-29																																																																																					
77	HCKT	Brasil_1	yes	no	no	no		low	no	no	31	no	06/14/18	06/19/18	No_active_therapy	3	KPC	CSLI	Tigecycline	4	I	100mg 12/12	2018-06-17	2018-07-03		Meropenem	>16	R	1g 8/8h	2018-06-15	2018-07-03		Fosfomycin		NR	3G/8/8	2018-06-17	2018-07-03		Ertapenem	>8	R	1 g 24/24h	2018-06-17	2018-07-03																																																																
78	HCKT	Brasil_1	yes	yes	yes	no	no	low	no	no	16	yes	10/21/18	10/25/18	CAZAVI	2	KPC	CLSI	Meropenem	>16	R	1g 24/24h	2018-10-21	2018-10-22	Microbiological report (previus cultures results)	Colistin	>16	R	150 mg 12/12h	2018-10-21	2018-11-06	Microbiological report	Fosfomycin		NR	3G/8/8	2018-10-23	2018-10-25	Not improvement	CAZ-AVI		S	2,5 8/8h	2018-10-25	2018-11-06																																																																
79	HCKT	Brasil_1	yes	no	no	no		low	yes	yes	31	no	11/07/19	11/10/19	No_active_therapy	3	KPC	CLSI	Fosfomycin			3g 24/24h	2019-11-11	2019-11-19		Meropenem	>16	R	1g 8/8h	2019-10-29	2019-11-19		Tigecycline	2	S	100mg/12/12	2019-11-10	2019-11-19																																																																							
80	HCKT	Brasil_1	yes	no	no	no		low	no	no	25	yes	08/25/19	08/30/19	COL	-5	KPC	CLSI	Amikacin	<2	S	750mg 24/24h	2019-08-22	2019-09-07	Not improvement	Meropenem	>16	R	1 gr 12/12	2019-08-20	2019-08-30	Not improvement	Colistin	<0,5	S	150 mg 12/12	2019-08-20	2019-09-07	Not improvement																																																																						
81	HCKT	Brasil_1	no	no	no	no		low	no	no	2	yes	07/16/20	07/20/20	No_active_therapy		KPC	CLSI	Meropenem	>16	R	500mg/8/8H	2020-07-10	2020-07-18		Polymyxin	>16	R	1MUI/12H	2020-07-10	2020-07-18																																																																														
82	HCKT	Brasil_1	yes	yes	no	yes	no	low	no	no	21	yes	07/30/20	08/04/20	COL	1	KPC	CLSI	Polymyxin	<0,5	S	750000ui/12/12H	2020-07-31	2020-08-20		Amikacin	<2	S	1g 24/24h	2020-08-04	2020-08-20																																																																														
83	HCKT	Brasil_1	yes	yes	no	yes	no	low	no	no	10	yes	02/07/20	02/11/20	COL	1	KPC	CLSI	Colistin	<0,5	S	150 mg 12/12	2020-02-08	2020-02-17		Amikacin	4	S	500 mg 48/48	2020-02-11	2020-02-11	Microbiological report	Tigecycline	2	S	100 mg 12/12	2020-02-11	2020-02-17																																																																							
84	HCKT	Brasil_1	yes	yes	yes	no	no	low	yes	yes	31	no	10/02/20	10/06/20	CAZAVI	1	KPC	CLSI	Colistin	>16	R	150 mg 24/24 h	2020-10-02	2020-10-03	Microbiological report	Meropenem	>16	R	1gr 24/24h	2020-10-02	2020-10-03	Microbiological report	CAZ-AVI	2	S	2,5 g 24/24h	2020-10-03	2020-10-24																																																																							
85	HCKT	Brasil_1	yes	yes	yes	no	no	low	no	no	11	yes	04/28/20	05/01/20	CAZAVI	3	KPC	CLSI	Meropenem	>16	R	1g 8/8h	2020-04-27	2020-05-01	Microbiological report	Tigecycline	2	S	50 mg 12/12h	2020-05-01	2020-05-09		CAZ-AVI	0.5	S	2,5 g 24/24h	2020-05-01	2020-05-09																																																																							
86	HCKT	Brasil_1	yes	no	no	no		low	yes	yes	31	no	11/21/20	11/25/20	No_active_therapy	7	KPC	CLSI	Piperacilin-Tazobactam	>128	R	4,5g 6/6h	2020-11-22	2020-11-24	Microbrological report	Amikacin	<2	S	400mg 24/24h	2020-11-24	2020-11-28	intolerance (hepatotoxicity)	CAZ-AVI	4	S	1,250 mg 24/24h	2020-11-28	2020-12-02																																																																							
87	HCKT	Brasil_1	yes	yes	yes	no	no	low	yes	yes	31	no	05/28/21	05/31/21	CAZAVI	-1	KPC	CLSI	CAZ-AVI		S	2,5g 8/8h	2021-05-27	2021-06-07																																																																																					
88	HCKT	Brasil_1	yes	yes	no	yes	no	low	no	no	8	yes	05/08/21	05/11/21	COL	0	KPC	CLSI	Meropenem	>16	R	1g 8/8h	2021-05-08	2021-05-10	Microbiological report	Colistin	<0,5	S	150mg 24/24h	2021-05-08	2021-05-16		Amikacin	<2	S	1g 24/24h	2021-05-10	2021-05-16																																																																							
89	La_Paz	Spain_6	yes	yes	no	yes	no	neutral	no	no	21	yes	08/19/16	08/22/16	MRP	1	OXA-48	EUCAST	Meropenem	1	S	2000/8 h	2016-08-20	2019-09-05		Fosfomycin	<=16	S	4000mg/6	2016-08-22	2016-09-05																																																																														
90	HPG23	Italy_5	yes	yes	no	yes	no	neutral	yes	yes	31	no	02/17/17	02/22/17	MRP/ERT	5	KPC	EUCAST	Meropenem	>8	R	2G/8H	2017-02-17	2017-02-28	Intolerance	Colistin	>8	R	4.5MU/12h	2017-02-22	2017-02-24	Unnecessary	Gentamicin	<1	S	320mg/24h	2017-02-22	2017-02-28	Intolerance	Ertapenem	>4	R	1g/24h	2017-02-22	2017-02-28	Intolerance																																																															
91	HPG23	Italy_5	yes	no	no	no		neutral	no	no	25	yes	04/20/17	04/26/17	MRP/ERT+TGC	3	KPC	EUCAST	Colistin	<0.5	S	2MU/12h	2017-04-23	2017-04-24	More  convenient alternative	Gentamicin	4	I	240mg/24H	2017-04-23	2017-04-24	More convenient alternative	Tigecycline	2	I	100mg/12h	2017-04-23	2017-05-15	Not improvement	Meropenem	>8	R	1G/8h	2017-04-24	2017-05-05	Not improvement	Ertapenem	>8	R	1g/24 h	2017-04-24	2017-05-05	Not improvement	CAZ-AVI		S	0.75mg/12h	2017-05-05	2017-05-15	Not improvement																																																	
92	HPG23	Italy_5	yes	yes	yes	no	no	neutral	no	yes	31	no	05/05/18	05/08/18	CAZAVI	4	KPC	EUCAST	Fosfomycin	2	S	8G/8h	2018-05-08	2018-06-21	Not improvement	Meropenem	>8	R	2G/8h	2018-05-08	2018-05-09	More convenient alternative	CAZ-AVI	4	S	2G/8h	2018-05-09	2018-06-21	Not improvement	Tigecycline	4	R	100mg/12h	2018-05-10	2018-06-21	Not improvement																																																															
93	HPG23	Italy_5	yes	yes	yes	no	yes	neutral	no	yes	31	no	05/12/18	05/14/18	CAZAVI+TGC	2	KPC	EUCAST	Meropenem	>8	R	2G/8h	2018-05-09	2018-05-14	Mirobiological report	Tigecycline	1	S	100mg/12h	2018-05-14	2018-06-21	Not improvement	CAZ-AVI		S	2G/8h	2018-05-14	2018-06-23	Not improvement																																																																						
94	HPG23	Italy_5	yes	yes	no	yes	no	neutral	no	no	12	yes	10/24/18	10/28/18	COL	2	KPC	EUCAST	Colistin	<0.5	S	1M/12h	2018-10-26	2018-10-29	Not improvement	Meropenem	>8	R	1G/12h	2018-10-26	2018-11-05	Non improvement	Tigecycline	>4	R	100mg/12h	2018-10-28	2018-11-05	Not improvement																																																																						
95	HPG23	Italy_5	yes	yes	yes	no	no	neutral	no	no	5	yes	10/06/19	10/07/19	CAZAVI	1	KPC	EUCAST	Meropenem	>8	R	1G/8H	2019-10-06	2019-10-07	Microbiological report	Fosfomycin		NR	8G/8h	2019-10-07	2019-10-10	Not improvement	CAZ-AVI	<0.5	S	2G/8h	2019-10-07	2019-10-10	Not improvement																																																																						
96	HPG23	Italy_5	yes	yes	yes	no	no	neutral	yes	yes	31	no	10/16/19	10/18/19	CAZAVI	2	KPC	EUCAST	Meropenem	>8	R	1G/8H	2019-10-16	2019-10-18	Microbiological report	CAZ-AVI	<0.5	S	2G/8H	2019-10-18	2019-10-30		Gentamicin	2	S	240mg/24h	2019-10-18	2019-10-30																																																																							
97	HPG23	Italy_5	yes	yes	no	yes	no	neutral	yes	yes	31	no	12/25/20	12/26/20	TGC	2	KPC	EUCAST	Meropenem	>8	R	1G/8H	2020-12-25	2020-12-27	Microbiological report	Tigecycline	1	S	50mg/12h	2020-12-27	2021-01-06																																																																														
98	HPG23	Italy_5	yes	yes	yes	no	no	neutral	yes	yes	31	no	05/14/21	05/17/21	CAZAVI	3	KPC	EUCAST	Ciprofloxacin	>2	R	400mg/8h	2021-05-16	2021-05-17	Microbiology report	CAZ-AVI	<0.12	S	2G/8h	2021-05-17	2021-05-27																																																																														
99	Hospital_Universitario_12_de_Octubre_	Spain_2	yes	yes	no	yes	yes	high	yes	yes	31	no	06/29/16	07/02/16	MRP+TGC	5	OXA-48	EUCAST	Piperacilin-Tazobactam	64	R	4000/500 mg /8H	2016-06-29	2016-07-04	Microbiological report	Meropenem	1	S	1000 mg/12 h	2016-07-04	2016-07-06	Intolerance	Tigecycline	<=1	S	100>50 mg/12h	2016-07-04	2016-07-06	Intolerance																																																																						
100	Hospital_Universitario_12_de_Octubre_	Spain_2	yes	yes	no	yes	no	high	yes	yes	31	no	07/16/16	07/19/16	MRP	0	OXA-48	EUCAST	Meropenem	<=2	S	1000 mg / 8h	2016-07-16	2016-07-26		Amikacin	<=8	S	1g/d	2016-07-16	2016-07-18	Unnecesary	Linezolid		NR	600 mg / 12h	2016-07-16	2016-07-18	Unnecesary																																																																						
101	Hospital_Universitario_12_de_Octubre_	Spain_2	yes	no	no	no		high	yes	yes	31	no	01/09/17	01/13/17	No_active_therapy		OXA-48	EUCAST	Cefuroxime	>16	R	500 mg/12 h	2017-01-10	2017-01-13	Microbiological report	Fosfomycin	<=16	S	500 mg /6 h	2017-01-13	2017-01-19																																																																														
102	Hospital_Universitario_12_de_Octubre_	Spain_2	yes	yes	no	yes	yes	high	no	no	31	no	10/24/17	10/26/17	MRP+TGC	0	OXA-48	EUCAST	Meropenem	No determinado	S	2000 mg / 8h extendida	2017-10-24	2017-11-30		Amikacin	<=8	S	1000 mg/24h	2017-10-24	2017-11-30		Tigecycline	1.5	S	100>50 mg/12h	2014-10-26	2017-11-30																																																																							
103	Hospital_Universitario_12_de_Octubre_	Spain_2	yes	yes	no	yes	no	high	yes	yes	31	no	06/09/17	06/12/17	MRP	4	OXA-48	EUCAST	Ertapenem	>4	R	1000 mg / 24h	2017-06-03	2017-06-12	Microbiological report	Meropenem		S	1000 mg/8h	2017-06-13	2017-06-19																																																																														
104	Hospital_Universitario_12_de_Octubre_	Spain_2	yes	no	no	no		high	no	no	31	no	12/19/17	12/21/17	MRP	0	OXA-48	EUCAST	Meropenem	0.75	S	1000 mg/8h	2017-12-19	2017-12-21	Not improvement	Tigecycline	<=1	S	100>50 mg /12h	2017-12-21	2017-12-26	Not improvement	Amikacin	<=8	S	1000 mg/d	2017-12-19	2018-01-01																																																																							
105	Hospital_Universitario_12_de_Octubre_	Spain_2	yes	yes	yes	no	no	high	yes	yes	31	no	01/05/18	01/09/18	CAZAVI	4	OXA-48	EUCAST	Ceftriaxone	>32	R	2000 mg /24h	2018-01-05	2018-01-09	Microbiological report	CAZ-AVI	0.5	S	2000 mg(8h	2018-01-09	2018-01-23																																																																														
106	Hospital_Universitario_12_de_Octubre_	Spain_2	yes	yes	yes	no	no	high	yes	yes	31	no	02/11/19	02/13/19	CAZAVI	0	OXA-48	EUCAST	Meropenem	0.5	S	1 g/12 h	2019-02-11	2019-02-12	Microbiological report	CAZ-AVI	0.75	S	2/0.5 g/8 h	2019-02-12	2019-03-04	End of therapy	Tigecycline	<=1	S	100 mg as loading dose, then 50 mg/12 h	2019-02-12	2019-02-14	Unnecesary																																																																						
107	Hospital_Universitario_12_de_Octubre_	Spain_2	yes	yes	yes	no	no	high	yes	yes	31	no	03/12/19	03/14/19	CAZAVI	0	OXA-48	EUCAST	Meropenem	3	I	500 mg/24 h	2019-03-12	2019-03-14	Microbiological report	CAZ-AVI	1	S	1/0.25 g/24 h	2019-03-14	2019-03-28	End of therapy																																																																													
108	Hospital_Universitario_12_de_Octubre_	Spain_2	yes	yes	no	yes	no	high	no	no	13	yes	04/24/19	04/27/19	MRP	0	OXA-48	EUCAST	Meropenem	2	S	2 g/8 h (extended perfusion)	2019-04-24	2019-05-03	Not improvement (death)																																																																																				
109	Hospital_Universitario_12_de_Octubre_	Spain_2	yes	yes	yes	no	no	high	yes	yes	31	no	04/24/19	04/25/19	CAZAVI	1	OXA-48	EUCAST	CAZ-AVI			2/0.5 g/8 h	2019-04-25	2019-04-29	End of therapy																																																																																				
110	Hospital_Universitario_12_de_Octubre_	Spain_2	yes	yes	yes	no	no	high	yes	yes	31	no	06/19/19	06/21/19	CAZAVI	5	OXA-48	EUCAST	Ceftriaxone	>32	R	1 g/24 h	2019-06-19	2019-06-20	Microbiological report	Ceftazidime	Not available	NR	1 g/8 h	2019-06-20	2019-06-21	Microbiological report	Meropenem	2	S	1 g/8 h	2019-06-20	2019-06-24	More convenient alternative	Colistin	<=2	S	2 millones UI/8 h	2019-06-22	2019-06-24	More convenient alternative	CAZ-AVI	<=2	S	2/0,5 g/8 h	2019-06-24	2019-07-08	End of therapy																																																								
111	Hospital_Universitario_12_de_Octubre_	Spain_2	yes	yes	yes	no	no	high	yes	yes	31	no	08/28/19	08/30/19	CAZAVI	0	OXA-48	EUCAST	CAZ-AVI			2/0.5 g/8 h	2019-08-28	2019-09-02	End of therapy	Amikacin	<=8	S	1 g/24 h	2019-08-28	2019-08-29	Unnecesary																																																																													
112	Hospital_Universitario_12_de_Octubre_	Spain_2	yes	yes	yes	no	yes	high	yes	yes	31	no	09/05/19	09/07/19	CAZAVI+TGC	1	OXA-48	EUCAST	Piperacilin-Tazobactam	>16	R	4/0.5 g/6 h	2019-08-29	2019-09-05	More convenient alternative	Amikacin	>16	R	1 g/24 h	2019-09-05	2019-09-06	Unnecesary	Meropenem	>32	R	1 g/8 h	2019-09-05	2019-09-06	Microbiological report	Tigecycline	<=1	S	100 mg/12 h	2019-09-06	2019-09-30	End of therapy	CAZ-AVI	<=2	S	2/0,5 g/8 h	2019-09-06	2019-09-30	End of therapy																																																								
113	Hospital_Universitario_12_de_Octubre_	Spain_2	yes	yes	yes	no	yes	high	no	no	26	yes	11/01/19	11/04/19	CAZAVI+TGC	0	OXA-48	EUCAST	Meropenem	1	S	2 g/8 h (extended perfusion)	2019-11-01	2019-11-04	More convenient alternative	Colistin	<=2	S	9 MU as loading dose, then 4.5 MU/12 h	2019-11-01	2019-11-05	More convenient alternative	Tigecycline	<=1	S	100 mg as loading dose, then 50 mg/12 h	2019-11-05	2019-11-27	Death	CAZ-AVI	0.75	S	1/0.25 g/8 h	2019-11-05	2019-11-27	Death																																																															
114	Hospital_Universitario_12_de_Octubre_	Spain_2	yes	yes	yes	no	no	high	yes	yes	31	no	07/07/20	07/10/20	CAZAVI	0	OXA-48	EUCAST	Meropenem	>8	R	2 g/8 h	2020-07-06	2020-07-07	Microbiological report (previous colonization with Klebsiella MDR)	CAZ-AVI	1	S	2/0.5 g/8 h	2020-07-07	2020-07-21	End of therapy																																																																													
115	Hospital_Universitario_12_de_Octubre_	Spain_2	yes	no	no	no		high	no	no	8	yes	07/07/20	07/09/20	CAZAVI	-17	OXA-48	EUCAST	CAZ-AVI	0.75	S	2/0.5 g/8 h	2020-06-20	2020-07-15	Death	Amikacin	<=8	S	1 g/24 h	2020-07-08	2020-07-10	Unnecesary																																																																													
116	Hospital_Universitario_12_de_Octubre_	Spain_2	yes	yes	no	yes	no	high	yes	yes	31	no	11/30/20	12/03/20	CEFTRIAX	0	OXA-48	EUCAST	Ceftriaxone	<=1	S	2 g/24 h	2020-11-30	2020-12-01	Not improvement	Ertapenem	>1	R	1 g/24 h	2020-12-01	2020-12-03	Microbiological report	CAZ-AVI	94	S	2/0.5 g/8 h	2020-12-03	2020-12-04	More convenient alternative	Ceftriaxone	<=1	S	2 g/24 h	2020-12-04	2020-12-11	More convenient alternative	Cefixime	<=4	S	200 mg/24 h	2020-12-11	2021-01-11	End of therapy																																																								
117	Hospital_Universitario_12_de_Octubre_	Spain_2	yes	yes	yes	no	yes	high	yes	yes	31	no	02/24/20	02/26/20	CAZAVI+TGC	2	OXA-48	EUCAST	Ceftriaxone	>16	R	1 g/24 h	2020-02-24	2020-02-26	Microbiological report	Tigecycline	<=1	S	100 mg as loading dose, then 50 mg/12 h	2020-02-26	2020-03-06	End of therapy	CAZ-AVI	125	S	2/0.5 g /8 h	2020-02-26	2020-03-06	End of therapy																																																																						
118	Hospital_Universitario_12_de_Octubre_	Spain_2	yes	yes	yes	no	yes	high	yes	yes	31	no	03/03/21	03/05/12	CAZAVI+TGC	0	OXA-48	EUCAST	Amikacin	<=8	S	500 mg/24 h	2021-03-03	2021-03-04	Unnecesary	Meropenem	16	R	1 g/12 h	2021-03-03	2021-03-09	Unnecesary and AE	CAZ-AVI	<=2	S	2/0.5 g/8 h	2021-03-05	2021-03-15	End of therapy	Tigecycline	<=1	S	100 mg as loading dose, then 50 mg/12 h	2021-03-05	2021-03-15	End of therapy																																																															
120	Hospital_Universitario_Marques_de_Valdecilla_	Spain_3	yes	yes	yes	no	yes	neutral	yes	yes	31	no	08/05/17	08/07/17	CAZAVI+COL+TGC	0	OXA-48	EUCAST	Meropenem	>16.0	R	2000mg/8h	2017-07-26	2017-08-09	Microbiological report	Colistin	<0.25	S		2017-08-05	2017-09-05		CAZ-AVI	<0.5	S		2017-08-09	2017-09-07		Amikacin	4.0	S		13/08/2017	22/08/2017		Tigecycline	2.0	I	50mg/12h	14/08/2017	07/09/2017																																																									
121	Hospital_Universitario_Marques_de_Valdecilla_	Spain_3	yes	yes	no	yes	no	neutral	yes	yes	31	no	11/06/17	11/07/17	MRP	1	OXA-48	EUCAST	Tigecycline	2.0	I	50mg/12h	2017-11-07	2017-11-10	Microbiological report	Ciprofloxacin	>=4.0	R	400mg/24h	2017-11-07	2017-11-08	Microbiological report	Gentamicin	<=1.0	S	120mg/24h	2017-11-08	2017-11-10	More convenient alternative (se inicia aminoglucosido hasta que alergologia valora desesnsibilización a Meropenem)	Meropenem	0.25	S	500mg/24h	10/11/2017	13/11/2017	More comvenient alternative (ajuste dosis)	Meropenem	0.25	S	1000mg/24h	13/11/2017	22/11/2017																																																									
122	Hospital_Universitario_Marques_de_Valdecilla_	Spain_3	yes	no	no	no		neutral	yes	yes	31	no	03/02/18	03/05/18	MRP+TGC	0	OXA-48	EUCAST	Meropenem	0.25	S	1000mg/8h	2018-03-02	2018-03-05	More convenient	Tigecycline	1.0	S	50mg/12h	2018-03-02	2018-03-06	More convenient alternative	Meropenem	0.25	S	2000mg/6h	2018-03-05	2018-04-09		Colistin	0.5	S	2MU/8h	06/03/2018	09/03/2018	More convenient alternative (deterioro de la función renal, se pone otro antibiótico)	CAZ-AVI	1.0 	S	2000mg/8h	09/03/2018	18/04/2018		Meropenem	0.25	S	1000mg/8h	2018-04-09	2018-04-18																																																		
123	Hospital_Universitario_Marques_de_Valdecilla_	Spain_3	yes	yes	yes	no	no	neutral	yes	yes	31	no	04/05/19	04/11/19	CAZAVI	5	OXA-48	EUCAST	Meropenem	32	R	500mg/24H	2019-04-04	2019-04-07		Meropenem		NR	1G/12H	2019-04-07	2019-04-10	Microbiological report	CAZ-AVI	1	S	1G/12H	2019-04-10	2019-04-10	Dosis change	CAZ-AVI	1	S	2G/8H	2019-04-10	2019-04-26	Treatment completed																																																															
124	Hospital_Universitario_Marques_de_Valdecilla_	Spain_3	yes	yes	yes	no	no	neutral	no	no	29	yes	07/10/19	07/12/19	CAZAVI	-2	OXA-48	EUCAST	Meropenem	2	S	500mg/12H	2019-07-08	2019-07-09		Meropenem	2	S	500mg/12H	2019-07-09	2019-07-11	Microbiological report	CAZ-AVI	1	S	800MG/48H	2019-07-10	2019-07-11		CAZ-AVI	1	S	800MG/24H	2019-07-11	2019-07-12	kidney function	CAZ-AVI	1	S	800MG/24H	2019-07-12	2019-07-17	kidney function	CAZ-AVI	1	S	2G/48H	2019-07-17	2019-07-22	kidney function	CAZ-AVI	1	S	2G/24H	2019-07-22	2019-07-26	kidney function	Amikacin	8	S	1G/24H	2019-07-16	2019-07-19	Toxicidad																																			
125	Hospital_Universitario_Marques_de_Valdecilla_	Spain_3	yes	yes	no	yes	no	neutral	yes	yes	31	no	10/08/20	10/13/20	MRP	1	OXA-48	EUCAST	Meropenem	1	S	1G/12H	2020-10-09	2020-10-13		Meropenem	1	S	2G/12H	2020-10-13	2020-10-16		Meropenem	1	S	2G/8H	2020-10-16	2020-10-22		Meropenem	2	S	1G/12H	2020-11-05	2020-11-10		CAZ-AVI	0.5	S	1G/12H	2020-11-10	2020-11-13		CAZ-AVI	0.5	S	1G/8H	2020-11-13	2020-11-24																																																		
128	Hospital_Ramón_y_Cajal_	Spain_4	yes	yes	yes	no	yes	high	yes	yes	31	no	05/03/17	05/09/17	CAZAVI+TGC+CIPRO	0	OXA-48	EUCAST	Meropenem		R	500mg/24h	2017-05-03	2017-05-05	More convenient alternative	Amikacin	<=8	S	600/24h	2017-05-03	2017-05-05	More convenient alternative	Tigecycline		NR	100/12h	2017-05-05	2017-05-23	End of treatment	CAZ-AVI		S	2000/12h	05/05/2017	23/05/2017	End of treatment	Ciprofloxacin	<=0,5	S	400/12h	05/05/2017	18/05/2017	End of treatment																																																								
130	Hospital_Universitario_Reina_Sofía_	Spain_1	yes	no	no	no		neutral	no	no	28	yes	12/12/16	12/14/16	No_active_therapy		KPC	EUCAST	Levofloxacin	>4	R	0,5g/24h	2016-11-21	2016-11-21		Piperacilin-Tazobactam	>64/5	R	IV: 0,4g/8h	2016-11-23	2016-12-13		Gentamicin	4	S	IV: 240mg/12h	2016-12-13	2016-12-16		Fosfomycin	64	S	IV: 0,4g/8h	2016-12-13	2016-12-13		Amoxi-clavu	<=4	S	1G/8H	2016-12-06	19/12/2016																																																									
131	Hospital_Universitario_Reina_Sofía_	Spain_1	no	no	no	no		neutral	no	no	1	yes	01/21/15	01/23/15	No_active_therapy		KPC		Tigecycline			50mg/12h	2015-01-19	2015-01-22																																																																																					
134	Hospital_Universitario_Reina_Sofía_	Spain_1	yes	yes	yes	no	no	neutral	no	no	31	no	09/28/18	10/02/18	CAZAVI	0	KPC		CAZ-AVI			2000mg/8h	2018-09-28	2018-09-29		CAZ-AVI		NR	1000mg/8h	2018-09-29	2018-09-30		Linezolid		NR	600mg/12h	2018-09-27	2018-09-27		TMP/SMX		NR	1600mg/8h	2018-09-04	2018-09-10		TMP/SMX		NR	800mg/24h	2018-09-10	2018-09-13		TMP/SMX		NR	800mg/8h	2018-09-13	2018-09-21																																																		
135	Hospital_Universitario_Reina_Sofía_	Spain_1	no	no	no	no		neutral	no	no	0	yes	03/29/19	04/02/19	No_active_therapy		KPC		Amoxi-clavu	>16	R	1000mg/12h	2019-03-26	2019-03-26		Cefazoline	>16	R	1000mg/24h	2019-03-28	2019-03-29		Cefuroxime	>16	R	750mg/12h	2019-03-26	2019-03-28		Ciprofloxacin	>2	R	400mg/12h	2019-03-22	2019-03-26		Meropenem	>16	R	1000mg/24h	2019-03-27	2019-03-29		Piperacillin/tazobactam	>64	R	4000mg/8h	2019-03-15	2019-03-22		Teicoplanin			400mg a las 16h	2019-03-20	2019-03-27																																											
136	ISMETT-UPMC_	Italy_1	yes	yes	no	yes	no	low	no	no	31	no	07/02/16	07/06/16	COL	5	KPC	EUCAST	Ertapenem	>8	R	1g/24h	2016-07-05	2016-07-13		Meropenem	>16	R	1g/6h	2016-07-05	2016-07-13		Amikacin	<2	S	1g/24h	2016-07-07	2016-07-08		Colistin	4	R	4.5MU/12h	08/07/2016	13/07/2016		Tigecycline	>8	R	50mg/12h	08/07/2016	13/07/2016																																																									
137	ISMETT-UPMC_	Italy_1	yes	no	no	no		low	no	no	28	yes	11/03/16	11/03/16	TGC	17	KPC	EUCAST	Meropenem	>=16	R	1G/8H	2016-11-03	2016-11-05		Colistin	>16	R	4.5MU/12h	2016-11-03	2016-11-06		Tigecycline	0.12	S	50mg/12h	2016-11-20	2016-12-01																																																																							
138	ISMETT-UPMC_	Italy_1	yes	yes	no	yes	yes	low	yes	yes	31	no	01/16/17	01/19/17	COL+AMG	2	KPC	EUCAST	Amikacin	<2	S	500/24H	2017-01-18	2017-01-30	UNECESSARY	Meropenem	>16	R	1G/8H	2017-01-16	2017-02-06		Ertapenem	/	NR	1G/24H	2017-01-16	2017-02-06	/																																																																						
139	ISMETT-UPMC_	Italy_1	yes	yes	no	yes	no	low	no	no	31	no	05/17/17	05/20/17	COL	3	KPC	EUCAST	Meropenem	>16	R	1G/8H	2017-05-17	2017-06-18	not improvement	Colistin	<0.5	S	4.5MU/12h	2017-05-20	2017-07-12	not improvement	Amikacin	>=64	R	1G/24H	2017-05-25	2017-06-11	not improvement	Ertapenem			2g/24h	29/05/2017	05/06/2017	not improvement	Tigecycline	1.5	I	50mg/12h	07/06/2017	12/07/2017	not improvement																																																								
140	ISMETT-UPMC_	Italy_1	yes	no	no	no		low	no	yes	31	no	09/05/17	09/08/17	TGC	0	KPC	EUCAST	Meropenem	>16	R	1G/8H	2017-09-02	2017-10-04	UNECESSARY	Colistin	>16	R	3,5M/12H	2017-09-02	2017-10-03	UNNECESSARY	Gentamicin	4	I	320MG/24H	2017-09-05	2017-09-12	not improvement																																																																						
141	ISMETT-UPMC_	Italy_1	yes	no	no	no		low	no	no	31	no	01/21/17	02/24/17	No_active_therapy		KPC	EUCAST	Meropenem	>=16	R	0.4g/8h	2017-01-16	2017-02-14	not improvement	Colistin	>=16	R	1MU/8h	2017-01-22	2017-01-24	more convenient alternative	Ertapenem		NR	250mg/12h	2017-01-16	2017-02-14	not improvement	Gentamicin	4	I	50mg/12h	24/01/2017	24/02/2017	not improvement	Fosfomycin	64	R	1g/6h	24/01/2017	09/03/2017																																																									
142	ISMETT-UPMC_	Italy_1	yes	no	no	no		low	yes	yes	31	no	01/31/17	02/03/17	No_active_therapy		KPC	EUCAST	Meropenem	>16	R	1G/8H	2017-02-01	2017-02-15		Ertapenem		NR	1G/24H	2017-02-10	2017-02-18		Amikacin	2	S	1G/24H	2017-01-31	2017-02-07	unnecessary																																																																						
143	ISMETT-UPMC_	Italy_1	yes	no	no	no		low	no	no	3	yes	01/07/17	01/11/17	No_active_therapy		KPC	EUCAST	Meropenem	>16	R	1g/8h	2017-01-02	2017-01-09	not improvement	Ertapenem		NR	1g/24h	2017-01-02	2017-01-09	not improvement																																																																													
144	ISMETT-UPMC_	Italy_1	yes	no	no	no		low	no	no	31	no	02/16/17	02/21/17	COL	13	KPC	EUCAST	Meropenem	>16	R	2g/8h	2017-02-16	2017-02-26		Ertapenem	>8	R	1g/24h	2017-02-18	2017-02-21		Colistin	<0.5	S	3.5MU/12h	2017-03-01	2017-03-24																																																																							
145	ISMETT-UPMC_	Italy_1	yes	yes	no	yes	no	low	yes	yes	31	no	03/31/17	04/02/17	COL	3	KPC	EUCAST	Meropenem	>16	R	1G/8H	2017-04-03	2017-04-25		Ertapenem		NR	1G/24H	2017-04-03	2017-04-23		Colistin	<0,5	S	3,5M/12H	2017-04-03	2017-04-09																																																																							
146	ISMETT-UPMC_	Italy_1	yes	no	no	no		low	yes	yes	31	no	11/18/17	12/22/17	COL	2	KPC	EUCAST	Meropenem	>16	R	1g/12h	2017-11-20	2017-11-30		Ertapenem	8	R	1g/24h	2017-11-20	2017-11-30		Colistin		NR	3.5MU/12h	2017-11-20	2017-11-29	not improvement	Tigecycline	4	R	100/12h	24/11/2017	31/12/2017	not improvement	Fosfomycin	32	S	4g/8h	01/01/2018	05/01/2018																																																									
147	ISMETT-UPMC_	Italy_1	yes	no	no	no		low	yes	yes	31	no	01/02/17	01/09/17	AMG	3	KPC	EUCAST	Ertapenem	>16	R	1G/24H	2017-01-03	2017-01-30		Gentamicin	4	I	100mg/48h	2017-01-05	2017-01-11	UNNCESARY	Tigecycline	4	R	50mg/12h	2017-01-09	2017-01-16																																																																							
148	ISMETT-UPMC_	Italy_1	yes	no	no	no		low	yes	yes	31	no	01/30/17	02/03/17	No_active_therapy	16	KPC	EUCAST	Meropenem	>16	R	1g/8h	2017-01-31	2017-02-27		Ertapenem		NR	1g/24h	2017-02-01	2017-02-26		Gentamicin	<1	S	260mg/24h	2017-02-15	2017-02-22																																																																							
149	ISMETT-UPMC_	Italy_1	yes	no	no	no		low	yes	yes	31	no	02/21/17	02/25/17	No_active_therapy		KPC	EUCAST	Meropenem	>16	R	1G/12H	2017-02-21	2017-04-03		Ertapenem		NR	1G/24H	2017-02-21	2017-04-01		Tigecycline	2	I	50MG/12H	2017-03-01	2017-03-21																																																																							
150	ISMETT-UPMC_	Italy_1	yes	no	no	no		low	yes	yes	31	no	04/21/17	04/26/17	No_active_therapy	6	KPC	EUCAST	Meropenem	>16	R	750MH/8H	2017-04-21	2017-05-15		Ertapenem		NR	500MG/24H	2017-04-21	2017-05-15		Fosfomycin	<16	S	2G/8H	2017-04-27	2017-05-02	INTOLERANCE																																																																						
151	ISMETT-UPMC_	Italy_1	yes	no	no	no		low	no	no	31	no	04/04/17	04/11/17	No_active_therapy		KPC	EUCAST	Meropenem	>16	R	1G/12H	2017-04-05	2017-05-11	MICROBIOLOGICAL REPORT	Ertapenem		NR	500MG/24H	2017-04-05	2017-05-01	NOT IMPROVEMENT	Tigecycline	2	I	100MG/12H	2017-04-11	2017-04-26	MICROBIOLOGICAL REPORT	Amikacin	2	S	500MG/48H	27/04/2017	03/05/2017	MICROBIOLOGICAL REPORT	Fosfomycin	<16	S	3G/6H	02/05/2017	22/05/2017	MORE CONVENIENT ALTERNATIVE	Colistin	<0,5	S	2,5M/12H	2017-05-11	2017-06-03	UNNECESARY	Tigecycline	2	I	100MG/12H	24/05/2017	03/06/2017	UNNECESARY	Colistin	<0,5	S	2,5M/12H	09/06/2017	11/07/2017																																				
152	ISMETT-UPMC_	Italy_1	yes	no	no	no		low	yes	yes	31	no	04/08/17	04/10/17	No_active_therapy		KPC	EUCAST	Meropenem	>16	R	1G/8H	2017-04-08	2017-04-19		Ertapenem		NR	1G/24H	2017-04-08	2017-04-19																																																																														
153	ISMETT-UPMC_	Italy_1	yes	no	no	no		low	yes	yes	31	no	04/16/17	04/20/17	No_active_therapy		KPC	EUCAST	Meropenem	>16	R	750MG/8H	2017-04-17	2017-05-08		Ertapenem		NR	500MG/24H	2017-04-17	2017-05-08		Amikacin	>=64	R	500MG/24H	2017-04-24	2017-05-07																																																																							
154	ISMETT-UPMC_	Italy_1	yes	yes	no	yes	no	low	yes	yes	31	no	08/16/17	08/19/17	MRP	3	OXA-48	EUCAST	Meropenem	1	S	1G/8H	2017-08-19	2017-08-29		Ertapenem		NR	1G/24H	2017-08-21	2017-08-29																																																																														
155	ISMETT-UPMC_	Italy_1	yes	yes	no	yes	no	low	no	no	31	no	07/20/17	07/23/17	TGC	3	KPC	EUCAST	Tigecycline			100mg/12h	2017-07-23	2017-08-07	Microbiological report	Colistin		NR	4.5MU/12h	2017-07-23	2017-08-07	MICROBIOLOGICAL REPORT	Meropenem		NR	0.75g/8h	2017-08-05	2017-08-28		Ertapenem			500mg/24h	05/08/2017	19/08/2017	NOT IMPROVEMENT					18/08/2017	28/08/2017		Tigecycline				2017-08-20	2017-08-28																																																		
156	ISMETT-UPMC_	Italy_1	yes	no	no	no		low	yes	yes	31	no	08/18/17	08/23/17	No_active_therapy		OXA-48	EUCAST	Meropenem	>16	R	1G/12H	2017-08-21	2017-08-28		Ertapenem		NR	500MG/24H	2017-08-21	2017-08-28																																																																														
157	ISMETT-UPMC_	Italy_1	yes	no	no	no		low	yes	yes	31	no	07/24/17	07/28/17	No_active_therapy		KPC	EUCAST	Meropenem	>16	R	1G/12H	2017-07-24	2017-08-03		Ertapenem		NR	500MG/24H	2017-07-24	2017-08-03																																																																														
158	ISMETT-UPMC_	Italy_1	yes	yes	no	yes	no	low	no	no	30	yes	08/06/17	08/10/17	COL	4	KPC	EUCAST	Meropenem	>16	R		2017-08-10	2017-09-05		Ertapenem	>8	R		2017-08-18	2017-08-30		Colistin	0.5	S		2017-08-10	2017-08-18	INTOLERANCE	Colistin	0.5	S		28/08/2017	05/09/2017		Tigecycline				20/08/2017	30/08/2017																																																									
159	ISMETT-UPMC_	Italy_1	yes	no	no	no		low	no	no	31	no	10/18/17	10/24/17	No_active_therapy	10	KPC	EUCAST	Amikacin	<2	S	1/24h	2017-10-23	2017-10-29	MICROBIOLOGICAL REPORT	Fosfomycin	<16	S	6g/6h	2017-10-23	2017-11-14	MICROBIOLOGICAL REPORT	Colistin	<0.5	S	3.5MU/12h	2017-11-24	2017-12-01	MICROBIOLOGICAL REPORT	Fosfomycin	<16	S	6g/6h	27/11/2017	13/12/2017		Amikacin	<2	S	1g/24h	27/11/2017	13/12/2017																																																									
160	ISMETT-UPMC_	Italy_1	yes	yes	no	yes	no	low	yes	yes	31	no	12/03/17	12/06/17	TGC	0	KPC	EUCAST	Amikacin	2	S	500MG/24H	2017-12-03	2017-12-12		Meropenem	>16	R	1G/12H	2017-12-04	2017-12-12		Tigecycline	1.5	I	50MG/12H	2017-12-05	2017-12-12																																																																							
161	ISMETT-UPMC_	Italy_1	yes	no	no	no		low	yes	yes	31	no	03/02/18	03/08/18	CAZAVI	7	KPC	EUCAST	Amikacin	2	S	500MG/24H	2018-03-06	2018-03-16																																																																																					
162	ISMETT-UPMC_	Italy_1	yes	yes	no	yes	no	low	yes	yes	31	no	03/05/18	03/09/18	TGC	1	OXA-48	EUCAST	Ertapenem	>16	R	120MG/24H	2018-03-06	2018-03-20		Meropenem	>16	R	160MH/8H	2018-03-08	2018-03-20		Tigecycline	1	S	8MH/12H	2018-03-06	2018-03-20		Fosfomycin	>128	R	850MG/8H	7/3/2018	19/03/2018																																																																
163	ISMETT-UPMC_	Italy_1	yes	yes	yes	no	no	low	yes	yes	31	no	03/09/18	02/20/18	CAZAVI	2	KPC	EUCAST	Fosfomycin	>256	R	4G/6H	2018-03-11	2018-03-13	MICROBIOLOGICAL REPORT	Tigecycline		NR	50MG/12H	2018-03-11	2018-03-13	MICROBIOLOGICAL REPORT	Amikacin	8	I	1G/24H	2018-03-11	2018-03-13	MICROBIOLOGICAL REPORT	CAZ-AVI	2	S	2,5/8H	13/03/2018	25/03/2018																																																																
164	ISMETT-UPMC_	Italy_1	yes	yes	yes	no	no	low	yes	yes	31	no	03/31/18	04/02/18	CAZAVI	0	KPC	EUCAST	Amikacin	2	S	1G/24H	2018-03-31	2018-04-02	MICROBIOLOGICAL REPORT	Colistin		R	4,5M/12H	2018-03-28	2018-04-09	MICROBIOLOGICAL REPORT	CAZ-AVI	2	S	2,5/8H	2018-04-03	2018-04-13																																																																							
165	ISMETT-UPMC_	Italy_1	yes	no	no	no		low	yes	yes	31	no	08/26/16	08/30/16	No_active_therapy		KPC	EUCAST	Amikacin	4	I	1G/24H	2016-08-28	2016-08-30		Ertapenem	8	R	1G/24H	2016-08-29	2016-09-04		Meropenem	>16	R	1g/8h	2016-08-28	2016-09-12																																																																							
166	ISMETT-UPMC_	Italy_1	yes	yes	no	yes	no	low	yes	yes	31	no	01/26/17	01/30/17	AMG	1	KPC	EUCAST	Meropenem	>16	R	1G/8H	2017-01-27	2017-02-03		Ertapenem	8	R	1G/24H	2017-01-27	2017-02-03		Gentamicin	1	S	240 MG/24H	2017-01-27	2017-02-03																																																																							
167	ISMETT-UPMC_	Italy_1	yes	yes	no	yes	no	low	yes	yes	31	no	10/01/17	10/05/17	TGC	3	KPC	EUCAST	Meropenem	>16	R	1G/8H	2017-10-04	2017-10-26		Tigecycline	0.5	S	50MG/12H	2017-10-04	2017-10-12	INTOLERANCE	Amikacin	2	S	1G/24H	2017-10-13	2017-10-18																																																																							
168	ISMETT-UPMC_	Italy_1	yes	yes	no	yes	no	low	yes	yes	31	no	02/08/17	02/10/17	MRP/ERT	0	KPC	EUCAST	Meropenem	16	S	1G/8H	2017-02-08	2017-02-14		Ertapenem	8	S	1G/24H	2017-02-08	2017-02-14		Gentamicin	>16	R	320,G/24H	2017-02-08	2017-02-14																																																																							
169	ISMETT-UPMC_	Italy_1	yes	yes	no	yes	no	low	yes	yes	31	no	03/26/17	03/29/17	COL	-1	KPC	EUCAST	Meropenem	>16	R	1G/24H	2017-03-25	2017-03-31		Meropenem	>16	R	1G/8H	2017-03-10	2017-04-26		Colistin	0.5	S	4M/12H	2017-03-27	2017-04-26																																																																							
170	ISMETT-UPMC_	Italy_1	yes	no	no	no		low	yes	yes	31	no	11/27/17	11/30/17	TGC	0	KPC	EUCAST	Meropenem	4	I	1/12h	2017-11-27	2017-12-14	more convinient alternative	Colistin	>16	R	3.5MU/12h	2017-11-30	2017-12-14	MORE CONVENIENT ALTERNATIVE	Tigecycline	1	S	100mg/12h	2017-12-03	2017-12-19		Ertapenem	>8	R	1g/24h	7/12/2017	13/12/2017	more convenient alternative																																																															
171	ISMETT-UPMC_	Italy_1	yes	yes	no	yes	yes	low	yes	yes	31	no	10/27/17	10/29/17	FMN+AMG	0	KPC	EUCAST	Meropenem	2	S	1G/8H	2017-10-27	2017-10-30	MORE CONVENIENT ALTERNATIVE	Ertapenem	8	R	1G/24H	2017-10-27	2017-10-30	More convenient alternative	Fosfomycin	<16	S	4G/8H	2017-10-29	2017-11-05		AMIKACIN	8	I	500 MG/24H	29/10/2017	4/11/2017																																																																
172	ISMETT-UPMC_	Italy_1	yes	no	no	no		low	yes	yes	31	no	12/14/17	12/16/17	No_active_therapy		KPC	EUCAST	Meropenem	>16	R	1g/24h	2017-12-15	2017-12-23		Ertapenem	>8	R	1g/24h	2017-12-15	2017-12-23		Fosfomycin	>256	R	2g/6h	2018-02-06	2018-02-20		AMIKACIN	16	I	1g/24h	13/02/2018	14/02/2018	unnecessary																																																															
173	ISMETT-UPMC_	Italy_1	yes	yes	yes	no	no	low	yes	yes	31	no	01/06/18	01/09/18	CAZAVI	3	OXA-48	EUCAST	Meropenem	4	I	1G/12H	2018-01-06	2018-01-09	MORE CONVENIENT ALTERNATIVE	Ertapenem		NR	1G/24H	2018-01-06	2018-01-07	MICROBIOLOGICAL REPORT	Tigecycline	0.5	s	50MG/12H	2018-01-06	2018-01-09	MORE CONVENIENT ALTERNATIVE	Fosfomycin	<16	S	4G/8H	09/01/2018	01/02/2018		CAZ-AVI	2	S	1,25/8H	09/01/2018	02/02/2018																																																									
174	ISMETT-UPMC_	Italy_1	yes	no	no	no		low	no	no	4	yes	01/16/18	01/18/18	No_active_therapy		OXA-48	EUCAST	Meropenem	4	I		2018-01-16	2018-01-20		Ertapenem	>8	R		2018-01-16	2018-01-20																																																																														
175	ISMETT-UPMC_	Italy_1	yes	no	no	no		low	no	no	10	yes	01/18/18	01/18/18	COL	-25	OXA-48	EUCAST	Colistin				2017-12-25	2018-01-23	MORE CONVENIENT ALTERNATIVE	Tigecycline		NR		2017-12-24	2018-01-26		Meropenem		NR		2018-01-19	2018-01-27		Fosfomycin				22/01/2018	28/01/2018																																																																
176	ISMETT-UPMC_	Italy_1	yes	yes	no	yes	no	low	yes	yes	31	no	02/12/18	02/14/18	AMG	0	KPC	EUCAST	Amikacin	4	S	1G/24H	2018-02-12	2018-03-02		Meropenem	>16	R	1G/8H	2018-02-13	2018-03-02		Ertapenem		NR	1G/24H	2018-02-12	2018-03-02																																																																							
177	ISMETT-UPMC_	Italy_1	yes	no	no	no		low	yes	yes	31	no	05/25/19	05/28/19	No_active_therapy		OXA-48	EUCAST	Ertapenem	>8	R	1G/24H	2019-05-26	2019-06-08		Meropenem	>16	R	1G/8H	2019-05-26	2019-06-09																																																																														Improvement
178	ISMETT-UPMC_	Italy_1	yes	no	no	no		low	no	no	31	no	03/19/19	03/22/19	No_active_therapy	13	KPC	EUCAST	Meropenem	>16	R	1G/6H	2019-03-20	2019-03-31		Meropenem	>16	R	1G/12H	2019-04-01	2019-04-12		Meropenem	>16	R	1G/8H	2019-04-13	2019-04-21		Amikacin	4	S	750MG/24H	2019-03-22	2019-03-31		Tigecycline	>8	R	50MG/12H	2019-03-19	2019-03-21	Intolerance	Fosfomycin	<16	S	3-4G/6H	19/03/2021	24/04/2021		CAZ-AVI	2	S	1.25G/8H	2019-04-01	2019-04-08		CAZ-AVI	2	S	2.5G/8H	2019-04-08	2019-04-17																																				Improvement
179	ISMETT-UPMC_	Italy_1	yes	yes	yes	no	no	low	yes	yes	31	no	11/19/20	11/21/20	CAZAVI	1	KPC	EUCAST	Amikacin			1G/24H	2020-11-19	2020-11-19		CAZ-AVI	8	S	2.5G/8H	2020-11-20	2020-11-22		CAZ-AVI	8	S	1.25G/8H	2020-11-22	2020-11-24		CAZ-AVI	8	S	2.5G/8H	2020-11-24	2020-12-02		Colistin		S	6MU/24H	2020-11-24	2020-11-25		Colistin		S	3MU/24h	25/11/2020	27/11/2020		Tobramycin	8	R	400MG/24H	2020-11-24	2020-11-24		Tigecycline	0.38		100MG/24H	2020-11-27	2020-11-27		Tigecycline	0.38	S	50MG/24H	2020-11-28	2020-12-05		Ampicillin	0.38	R	1G/12H	2020-11-17	2020-11-30		Fosfomycin			3G/8H	23/11/2020	2020-11-26															not improvement or deterioration
180	ISMETT-UPMC_	Italy_1	yes	yes	yes	no	no	low	yes	yes	31	no	07/20/20	07/23/20	CAZAVI	1	KPC	EUCAST	CAZ-AVI	<1	S	2.5G/8H	2020-07-21	2020-08-04		Tigecycline		NR	100MG/24H	2020-07-27	2020-07-27		Tigecycline		NR	50MG/12H	2020-07-27	2020-08-03																																																																							not improvement or deterioration
181	ISMETT-UPMC_	Italy_1	yes	no	no	no		low	yes	yes	31	no	02/02/20	02/04/20	CAZAVI	7	KPC	EUCAST	Piperacilin-Tazobactam	>64	R	2.25G/8H	2020-02-02	2020-02-03	Microbiological report	CAZ-AVI	0.5	S	0.94G/24H	2020-02-03	2020-02-10		CAZ-AVI	0.5	S	0.94G/12H	2020-02-11	2020-02-12		CAZ-AVI	0.5	S	1.25G/8H	2020-02-12	2020-02-21		Fosfomycin		NR	2G/12H	2020-02-03	2020-02-10		Fosfomycin		NR	4G/8H	10/02/2020	18/02/2020		Fosfomycin		NR	2G/8H	2020-02-18	2020-02-23																																											not improvement or deterioration
182	ISMETT-UPMC_	Italy_1	yes	yes	yes	no	no	low	no	no	31	no	12/23/20	12/29/20	CAZAVI	2	KPC	EUCAST	Levofloxacin			500MG/24H	2020-12-23	2020-12-25	Microbiological report	Daptomycin		R	500MG/24H	2020-12-22	2020-12-24	Microbiological report	Amikacin	2	S	1G/24H	2020-12-24	2020-12-24	Microbiological report	CAZ-AVI	1	S	2.5G/8H	2020-12-25	2021-01-13		Fosfomycin		NR	4G/6H	2020-12-25	2020-02-04		Amikacin	2	S	1G/24H	29/12/2020	29/12/2020		Amikacin	2	S	1G/48H	2020-12-31	2020-12-31		Amikacin	2	S	1G/24H	2021-01-05	2021-01-05		Amikacin	2	S	1MG/24H	2021-01-19	2021-01-20		CAZ-AVI	1	S	2.5G/8H	2021-01-18	2021-02-04																						not improvement or deterioration
183	ISMETT-UPMC_	Italy_1	yes	yes	yes	no	no	low	yes	yes	31	no	11/16/20	11/20/20	CAZAVI	1	KPC	EUCAST	Amikacin	4	S	500MG/24H	2020-11-16	2020-11-16		Meropenem	>8	R	1G/12H	2020-11-16	2020-11-17	Microbiological report	CAZ-AVI	4	S	0.95G/8H	2020-11-17	2020-11-18		CAZ-AVI	4	S	2.5G/8H	2020-11-18	2020-11-30		CAZ-AVI	4	S	1.25G/8H	2020-11-30	2020-12-13		Fosfomycin		NR	3G/24H	17/11/2020	02/12/2020		Fosfomycin		NR	2G/12H	2020-12-02	2020-12-15																																											not improvement or deterioration
184	ISMETT-UPMC_	Italy_1	yes	yes	yes	no	no	low	yes	yes	31	no	02/18/20	02/21/20	CAZAVI	1	KPC	EUCAST	Piperacilin-Tazobactam	>64	R	2.25G/8H	2020-02-17	2020-02-20	Microbiological report	Meropenem	>8	R	1G/24H	2020-02-19	2020-02-19	Microbiological report	Amikacin	4	S	750MG/24H	2020-02-18	2020-02-18		Amikacin	4	S	750MG/24H	2020-02-21	2020-02-21		CAZ-AVI	2	S	0.95G/24H	2020-02-19	2020-02-23		CAZ-AVI	2	S	0.95G/12H	23/02/2020	02/03/2020		Fosfomycin	32	S	4G/24H	2020-02-19	2020-02-20		Fosfomycin	32	S	2G/8H	2020-02-20	2020-02-23																																				not improvement or deterioration
185	ISMETT-UPMC_	Italy_1	yes	yes	yes	no	yes	low	yes	yes	31	no	06/15/20	06/18/20	CAZAVI+TGC+COL	0	KPC	EUCAST	Amikacin	<1	S	1000MG/24H	2020-06-15	2020-06-15		CAZ-AVI	0.5	S	1.25G/8H	2020-06-15	2020-06-17		CAZ-AVI	0.5	S	2.5G/8H	2020-06-17	2020-06-27		Tigecycline	1	S	100MG/12H	2020-06-15	2020-06-27		Colistin		S	6000000U/24H	2020-06-20	2020-06-21		Colistin		S	350000U/12H	21/06/2020	23/06/2020																																																		not improvement or deterioration
186	ISMETT-UPMC_	Italy_1	yes	no	no	no		low	no	no	31	no	04/13/20	04/15/20	MRP	-9	OXA-48	EUCAST	Amikacin	4	S	750MG/48H	2020-04-07	2020-04-23		Meropenem	1	S	1G/8H	2020-04-04	2020-05-15																																																																														not improvement or deterioration
187	ISMETT-UPMC_	Italy_1	yes	no	no	no		low	yes	yes	31	no	03/29/20	04/01/20	TGC	-4	KPC	EUCAST	CAZ-AVI	>16	R	0.95G/48H	2020-03-24	2020-04-02		CAZ-AVI	>16	R	0.95G/24H	2020-04-02	2020-04-09		CAZ-AVI	>16	R	1.25G/8H	2020-04-09	2020-04-14	Microbiological report	Amikacin	4	S	750MG/24H	2020-03-25	2020-03-25		Amikacin	4	S	500MG/24H	2020-03-31	2020-03-31		Tigecycline	4	S	50MG/12H	24/03/2020	13/04/2020		Tigecycline	4	S	100MG/12H	2020-04-13	2020-04-19		Fosfomycin	128	R	2G/48H	2020-03-25	2020-04-02		Fosfomycin	128	R	2G/12H	2020-04-02	2020-04-06		Fosfomycin	128	R	2G/8H	2020-04-06	2020-04-09		Fosfomycin	128	R	3G/6-8H	2020-04-09	2020-04-14	Microbiological report	Meropenem	<0.25	S	1G/8H	2020-04-14	2020-04-19		Meropenem	<0.25	S	0.5G/12H	2020-04-19	2020-04-27	not improvement or deterioration
188	ISMETT-UPMC_	Italy_1	yes	yes	yes	no	no	low	yes	yes	31	no	05/12/21	05/15/21	CAZAVI	-3	KPC	EUCAST	Amikacin	>32	R	1G/24H	2021-05-12	2021-05-12	More convenient alternative	Colistin	8	R	9MU/24H	2021-05-12	2021-05-12		Daptomycin	1	S	480MG/24H	2021-05-12	2021-05-13	More convenient alternative	Tigecycline	1	S	100MG/24H	2021-05-12	2021-05-12		Tigecycline	1	S	50MG/12H	2021-05-14	2021-05-19		Tigecycline	1	S	100MG/12H	19/05/2021	30/05/2021		CAZ-AVI	8	S	2.5GR/8H	2021-05-08	2021-05-13		Colistin	8	R	3MU/8h	2021-05-13	2021-05-14	More convenient alternative																																			not improvement or deterioration
189	ISMETT-UPMC_	Italy_1	yes	yes	no	yes	no	low	no	no	9	yes	05/27/16	05/31/16	MRP/ERT	0	KPC	EUCAST	Ertapenem	1	S	500/24	2016-05-27	2016-06-05	Death	Meropenem	8	S	500/12	2016-05-27	2016-06-05	Death																																																																													
190	ISMETT-UPMC_	Italy_1	yes	yes	no	yes	no	low	no	no	31	no	03/11/16	03/14/16	MRP/ERT	0	KPC	EUCAST	Gentamicin	2	S	160/24	2016-03-11	2016-04-18	Death	Meropenem	8	S	1000/12	2016-03-11	2016-04-18	Death	Ertapenem	8	S	1000/24	2016-03-11	2016-04-18	Death																																																																						
191	ISMETT-UPMC_	Italy_1	yes	yes	no	yes	no	low	yes	yes	31	no	02/17/16	02/20/16	MRP/ERT	0	KPC	EUCAST	Gentamicin	4	R	160/24	2016-02-17	2016-02-21	Microbiological report	Ertapenem	1	S	1000/24	2016-02-17	2016-03-22	End of Therapy	Meropenem	8	S	1000/8	2016-02-17	2016-03-22	End of Therapy																																																																						
192	Icahn	USA_1	yes	yes	yes	no	no	neutral	no	no	31	no	07/30/18	08/02/18	CAZAVI	1	KPC	EUCAST	Meropenem		R	1gm IV q12	2018-07-26	2018-08-01	Microbiological report	Gentamicin	<1	S	520 mg IV x 1	2018-07-31	2018-07-31	Microbiological report	CAZ-AVI	1.5	S	1.25 gm IV q8	2018-08-01	2018-08-12	Microbiological report	Polymyxin	0.5	Susc	1,1110,000 units q12	16/08/2018	27/08/2018	Microbiological report	CAZ-AVI	8	Susceptible	1.25 gm IV q8	28/08/2018	11/09/2018	Death	Tigecycline	1	Susceptible	50 mg IV q12	28/08/2018	11/09/2018	death	Amikacin	<2	Suscpetible	1314 mg x 1	14/08/2018	27/08/2018	More convenient alternative																																										
193	Icahn	USA_1	yes	yes	yes	no	no	neutral	yes	yes	31	no	04/27/18	04/30/18	CAZAVI	-1	KPC	EUCAST	CAZ-AVI	0.75	S	1.25 gm IV q8	2018-04-26	2018-05-15																																																																																					
194	Icahn	USA_1	yes	yes	yes	no	no	neutral	no	no	11	yes	05/16/17	05/19/17	CAZAVI	1	KPC	EUCAST	Meropenem		R	1gm IV q24	2017-05-17	2017-05-19	Microbiological report	Amikacin	4	S	732 mg IV x 1	2017-05-18	2017-05-18	Microbiological report	CAZ-AVI	125	S	0.94 gm IV q24	2017-05-18	2017-05-27	Not improvement/death																																																																						
195	Icahn	USA_1	yes	no	no	no		neutral	yes	yes	31	no	03/28/16	04/04/16	No_active_therapy		KPC	EUCAST																																																																																											
196	Pisa	Italy_3	yes	yes	no	yes	yes	high	no	no	14	yes	02/24/16	02/25/16	COL+TGC	1	KPC	EUCAST	Colistin		S	4.5 UI/12H	2016-02-25	2016-03-09	DEATH	Gentamicin		S	240 MG/24H	2016-02-25	2016-03-09		Tigecycline		S	100/12H	2016-02-25	2016-03-09																																																																							
197	Pisa	Italy_3	yes	yes	no	yes	no	high	yes	yes	31	no	11/09/16	11/11/16	TGC	1	KPC	EUCAST	Tigecycline		S	100 MG/12H	2016-11-10	2016-11-22		Fosfomycin		S	4G/6H	2016-10-11	2016-10-22																																																																														
198	Pisa	Italy_3	yes	yes	yes	no	no	high	yes	yes	31	no	05/20/16	05/22/16	CAZAVI	-1	KPC	EUCAST	Imipenem		R	1/1 G/8H	2016-05-19	2016-05-20	Microbiological report	Colistin		S	4.5 M/12H	2016-05-19	2016-05-20	Intolerance (AKI)	CAZ-AVI		S	1.25G/8H	2016-05-21	2016-05-30																																																																							
199	Pisa	Italy_3	yes	yes	no	yes	no	high	yes	yes	31	no	06/07/17	06/09/17	COL	2	KPC	EUCAST	Piperacilin-Tazobactam		R	4.5 G/8H	2017-06-07	2017-06-09	Microbiological report	Colistin		S	4.5 MI/12H	2017-06-09	2017-06-19		Fosfomycin		S	4G/8H	2017-06-09	2017-06-19																																																																							
200	Pisa	Italy_3	yes	yes	no	yes	no	high	no	no	31	no	07/04/17	07/07/17	COL	5	KPC	EUCAST	Meropenem		R	1 G/12H	2017-07-05	2017-07-09	Microbiological report	Colistin		S	2 MI/12H	2017-07-09	2017-07-17		Fosfomycin		S	2 G/8H	2017-07-09	2017-07-17																																																																							
201	Pisa	Italy_3	yes	yes	no	yes	no	high	no	no	31	no	05/24/17	05/26/17	COL	2	KPC	EUCAST	Piperacilin-Tazobactam		R	2.25 G/6H	2017-05-24	2017-05-26	Microbiological report	Colistin		S	3 MI/12H	2017-05-26	2017-06-03		Meropenem		R	1G/8H	2017-05-26	2017-06-03																																																																							
202	Pisa	Italy_3	no	no	no	no		high	no	no	0	yes	12/12/18	12/14/18	No_active_therapy		KPC	EUCAST	Piperacilin-Tazobactam		R	4.5 G/8H	2018-12-11	2018-12-12	Death																																																																																				
203	Pisa	Italy_3	yes	no	no	no		high	yes	yes	31	no	05/21/18	05/31/18	AMG	10	KPC	EUCAST	Tigecycline		S	50 G712H	2018-05-31	2018-06-03	transfer to other facility	Gentamicin		S	160/24H	2018-05-31	2018-06-03	transfer to other facility																																																																													
204	Pisa	Italy_3	yes	yes	yes	no	no	high	no	no	13	yes	11/17/18	11/18/18	CAZAVI	1	KPC	EUCAST	Fosfomycin		R	3G/6H	2018-11-17	2018-11-18	Microbiological report	Gentamicin		S	240 mg/24H	2018-11-17	2018-11-30	death	CAZ-AVI		S	2.5 G/8H	2018-11-18	2018-11-30	death																																																																						
205	Pisa	Italy_3	yes	yes	yes	no	yes	high	yes	yes	31	no	07/16/19	07/17/19	CAZAVI+TGC	0	KPC	EUCAST	CAZ-AVI		S	2.5G/8H	2019-07-16	2019-07-26		Tigecycline	<0.5	S	50 MG/12H	2019-07-18	2019-07-26																																																																														
206	Pisa	Italy_3	yes	yes	yes	no	no	high	yes	yes	31	no	01/18/19	01/20/19	CAZAVI	1	KPC	EUCAST	Piperacilin-Tazobactam		R	2.25 G/8H	2018-01-13	2018-01-19	Microbiological report	CAZ-AVI		S	1.25 G/8H	2019-01-19	2019-01-29																																																																														
207	Pisa	Italy_3	yes	yes	yes	no	no	high	yes	yes	31	no	07/27/19	07/30/19	CAZAVI	3	KPC	EUCAST	Piperacilin-Tazobactam		R	2.25 G/6H	2019-07-27	2019-07-30	Microbiological report	CAZ-AVI		S	2.5 G/8H	2019-07-30	2019-08-07		Fosfomycin		S	4G/8H	2019-07-30	2019-08-04	Intolerance (hypernatriemia)																																																																						
208	Pisa	Italy_3	yes	yes	yes	no	no	high	yes	yes	31	no	08/18/19	08/19/19	CAZAVI	1	KPC	EUCAST	CAZ-AVI		S	2.5 G/8H	2019-08-19	2019-09-02																																																																																					
209	Pisa	Italy_3	yes	yes	yes	no	no	high	yes	yes	31	no	07/20/19	07/23/19	CAZAVI	3	KPC	EUCAST	CAZ-AVI		S	1.25/8H	2019-07-23	2019-07-29																																																																																					
210	Pisa	Italy_3	yes	yes	no	yes	no	high	no	no	9	yes	07/20/19	07/22/19	COL	0	KPC	EUCAST	Colistin		S	3 M/12H	2019-07-20	2019-07-29	Intolerance and death	Fosfomycin		S	2 G/8H	2019-07-20	2019-07-27																																																																														
211	Pisa	Italy_3	yes	yes	yes	no	no	high	yes	yes	31	no	12/11/19	12/13/19	CAZAVI	0	KPC	EUCAST	CAZ-AVI		S	2.5G/8H	2019-12-11	2019-12-19																																																																																					
212	Pisa	Italy_3	yes	yes	yes	no	no	high	yes	yes	31	no	02/11/19	02/12/19	CAZAVI	0	KPC	EUCAST	Colistin		S	3M/12h	2019-02-11	2019-02-13	More convenient alternative	Fosfomycin		R	3G/8H	2019-02-11	2019-02-13	Microbiological report	CAZ-AVI		S	1.25G/8H	2019-02-13	2019-03-03																																																																							
213	Pisa	Italy_3	yes	yes	yes	no	no	high	yes	yes	31	no	10/02/19	10/04/19	CAZAVI	1	KPC	EUCAST	CAZ-AVI		S	2.5G/8H	2019-10-03	2019-10-07																																																																																					
214	Pisa	Italy_3	yes	yes	yes	no	no	high	yes	yes	31	no	10/17/20	10/18/20	CAZAVI	1	KPC	EUCAST	CAZ-AVI		S	2.5 G/8H	2020-10-18	2020-10-30																																																																																					
215	Pisa	Italy_3	yes	yes	yes	no	no	high	yes	yes	31	no	09/22/20	09/23/20	CAZAVI	0	KPC	EUCAST	CAZ-AVI		S	2.5G/8H	2020-09-22	2020-10-07		Tigecycline		S	100 G/12H	2020-09-22	2020-09-25	Unnecessary																																																																													
216	Pisa	Italy_3	yes	yes	yes	no	no	high	yes	yes	31	no	05/07/20	05/08/20	CAZAVI	0	KPC	EUCAST	CAZ-AVI		S	2.5G/8H	2020-05-07	2020-05-17																																																																																					
217	Pisa	Italy_3	no	no	no	no		high	no	no	1	yes	03/20/21	03/21/21	No_active_therapy		KPC	EUCAST																																																																																											
218	Pisa	Italy_3	yes	yes	yes	no	no	high	yes	yes	31	no	06/17/21	06/17/21	CAZAVI	0	KPC	EUCAST	CAZ-AVI		S	1.25 G/8H	2021-06-17	2021-07-11		Fosfomycin		S	3G/8H	2021-06-17	2021-07-02	Unnecessary																																																																													
219	Pisa	Italy_3	yes	yes	yes	no	no	high	yes	yes	31	no	06/20/21	06/22/21	CAZAVI	0	KPC	EUCAST	CAZ-AVI		S	2.5 G/8H	2021-06-20	2021-07-07		Metronidazole		NR	500G/8H	2021-06-20	2021-06-30	Unnecessary																																																																													
220	Ospedale_San_Matteo	Italy_2	yes	no	no	no		neutral	no	no	31	no	02/21/18	02/23/18	No_active_therapy	12	KPC	EUCAST	Meropenem	8	R	2/8 h	23/02/2018	05/03/2018	more convenient alternative	Tigecycline	0.5	S	100/12 h	23/02/2018	19/03/2018		CAZ-AVI		NR	2.5/8h	05/03/2018	19/03/2018																																																																							
221	Ospedale_San_Matteo	Italy_2	yes	yes	yes	no	yes	neutral	yes	yes	31	no	09/17/19	09/20/19	CAZAVI+TGC	0	KPC	EUCAST	Ceftazidime	>8	R		2019-09-17	2019-09-20	microbiological report	CAZ-AVI		S	2.5g/8	2019-09-20	2019-10-01	Cure	Tigecycline		NR	100mg/12	2019-09-20	2019-10-01	Cure																																																																						
222	Ospedale_San_Matteo	Italy_2	yes	yes	yes	no	no	neutral	yes	yes	31	no	05/09/20	05/10/20	CAZAVI	1	KPC	EUCAST	CAZ-AVI	4	S	1.25g/8h	2020-05-10	2020-05-15	cure	Fosfomycin	32	S	3g/8h	2020-05-10	2020-05-15	Cure																																																																													
223	Ospedale_San_Matteo	Italy_2	yes	yes	yes	no	no	neutral	yes	yes	31	no	01/19/21	01/22/21	CAZAVI	3	KPC	EUCAST	CAZ-AVI	1	S	1G/48h (hemodialysis)	2021-01-22	2021-02-04	cure	Meropenem	>16	R	500mg/12h	2021-01-22	2021-02-04	cure																																																																													
224	Ospedale_San_Matteo	Italy_2	yes	yes	no	yes	no	neutral	yes	yes	31	no	04/30/21	06/02/21	MRP	2	KPC	EUCAST	Piperacilin-Tazobactam	>16/4	R		2021-04-30	2021-05-02	Not improvement	Meropenem-Varbobactam	1	S	4g/6h	2021-05-02	2021-05-14	cure																																																																													
